Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


Articles published in Hepatology

Retrieve available abstracts of 757 articles:
HTML format
Text format



Single Articles


    May 2019
  1. TRIVEDI HD, Lau DTY, Kulai TB, Malhi H, et al
    Hepatology Highlights.
    Hepatology. 2019;69:1849-1851.
    PubMed     Text format    


    April 2019
  2. HAGE C, Hoves S, Strauss L, Bissinger S, et al
    Sorafenib Induces Pyroptosis in Macrophages and Triggers NK Cell-Mediated Cytotoxicity Against Hepatocellular Carcinoma.
    Hepatology. 2019 Apr 19. doi: 10.1002/hep.30666.
    PubMed     Text format     Abstract available


  3. SANYAL AJ, Harrison SA, Ratziu V, Abdelmalek MF, et al
    The Natural History of Advanced Fibrosis due to Nonalcoholic Steatohepatitis: Data from the Simtuzumab Trials.
    Hepatology. 2019 Apr 16. doi: 10.1002/hep.30664.
    PubMed     Text format     Abstract available


  4. YANG HD, Kim HS, Kim SY, Na MJ, et al
    HDAC6 Suppresses Let-7i-5p to Elicit TSP1/CD47-mediated Anti-tumorigenesis and Phagocytosis of Hepatocellular Carcinoma.
    Hepatology. 2019 Apr 16. doi: 10.1002/hep.30657.
    PubMed     Text format     Abstract available


  5. DO A, Kuszewski EJ, Mehal WZ
    Incorporating Weight Loss Medications into Hepatology Practice for Nonalcoholic Steatohepatitis.
    Hepatology. 2019 Apr 16. doi: 10.1002/hep.30658.
    PubMed     Text format     Abstract available


  6. LIU R, Li X, Zhu W, Wang Y, et al
    Cholangiocyte-derived exosomal LncRNA H19 promotes hepatic stellate cell activation and cholestatic liver fibrosis.
    Hepatology. 2019 Apr 15. doi: 10.1002/hep.30662.
    PubMed     Text format     Abstract available


  7. HE Y, Hwang S, Cai Y, Kim SJ, et al
    MicroRNA-223 ameliorates nonalcoholic steatohepatitis and cancer by targeting multiple inflammatory and oncogenic genes in hepatocytes.
    Hepatology. 2019 Apr 9. doi: 10.1002/hep.30645.
    PubMed     Text format     Abstract available


  8. DESROCHES-CASTAN A, Tillet E, Ricard N, Ouarne M, et al
    BMP9 is a paracrine factor controlling liver sinusoidal endothelial cell fenestration and protecting from hepatic fibrosis.
    Hepatology. 2019 Apr 9. doi: 10.1002/hep.30655.
    PubMed     Text format     Abstract available


  9. LI N, Wei L, Liu X, Bai H, et al
    A frizzled-like cysteine rich domain in glypican-3 mediates Wnt binding and regulates hepatocellular carcinoma tumor growth in mice.
    Hepatology. 2019 Apr 9. doi: 10.1002/hep.30646.
    PubMed     Text format     Abstract available


  10. CHEN YJ, Tsai CF, Wang YP, Lu CL, et al
    To the editor: Proton pump inhibitors are associated to minimal and overt hepatic encephalopathy and increase mortality in cirrhotics.
    Hepatology. 2019 Apr 8. doi: 10.1002/hep.30641.
    PubMed     Text format     Abstract available


  11. DHANASEKARAN R, Felsher DW
    A Tale of Two Complications of Obesity: Nonalcoholic steatohepatitis (NASH) and Hepatocellular carcinoma (HCC).
    Hepatology. 2019 Apr 8. doi: 10.1002/hep.30649.
    PubMed     Text format     Abstract available


  12. VUPPALANCHI R, Chalasani N
    HEP-18-0797.R2 - Liver Stiffness Measurements in Patients with Non-cirrhotic Portal Hypertension - The Devil is In the Details.
    Hepatology. 2019 Apr 5. doi: 10.1002/hep.30640.
    PubMed     Text format     Abstract available


  13. MOON AM, Hayashi PH, Barritt AS 4th
    Proton pump inhibitors in cirrhosis: a marker of morbid conditions or cause of mortality.
    Hepatology. 2019 Apr 5. doi: 10.1002/hep.30642.
    PubMed     Text format     Abstract available


  14. NARDELLI S, Gioia S, Ridola L, Farcomeni A, et al
    PPIs in cirrhosis: more evidences for a careful prescription!
    Hepatology. 2019 Apr 4. doi: 10.1002/hep.30639.
    PubMed     Text format     Abstract available


  15. NAIR KM, Vora RS, Mousa OY, Malhi H, et al
    Hepatology Highlights.
    Hepatology. 2019;69:1365-1368.
    PubMed     Text format    


  16. ZHOU SL, Yin D, Hu ZQ, Luo CB, et al
    A Positive Feedback Loop between Cancer Stem-Like Cells and Tumor- Associated Neutrophils Controls Hepatocellular Carcinoma Progression.
    Hepatology. 2019 Apr 1. doi: 10.1002/hep.30630.
    PubMed     Text format     Abstract available


    March 2019
  17. BROWN ZJ, Greten TF, Heinrich B
    Adjuvant Treatment of Hepatocellular Carcinoma: Prospect of Immunotherapy.
    Hepatology. 2019 Mar 30. doi: 10.1002/hep.30633.
    PubMed     Text format     Abstract available


  18. KAO WY, Tan EC, Su CW
    Reply to comment: Proton Pump Inhibitor Use and Risk of Hepatocellular Carcinoma.
    Hepatology. 2019 Mar 30. doi: 10.1002/hep.30632.
    PubMed     Text format     Abstract available


  19. ELKRIEF L, Ferrusquia-Acosta J, Payance A, Moga L, et al
    Abdominal surgery in patients with idiopathic noncirrhotic portal hypertension: a multicenter retrospective study.
    Hepatology. 2019 Mar 29. doi: 10.1002/hep.30628.
    PubMed     Text format     Abstract available


  20. RUSSELL BE, Whaley KG, Bove KE, Labilloy A, et al
    Expanding and Underscoring the Hepato-Encephalopathic Phenotype of QIL1/MIC13.
    Hepatology. 2019 Mar 26. doi: 10.1002/hep.30627.
    PubMed     Text format     Abstract available


  21. YANG J, Trepo E, Nahon P, Cao Q, et al
    A HSD17B13 variant protects from hepatocellular carcinoma development in alcoholic liver disease.
    Hepatology. 2019 Mar 25. doi: 10.1002/hep.30623.
    PubMed     Text format     Abstract available


  22. WANG YL, Liu JY, Yang JE, Yu XM, et al
    Lnc-UCID promotes G1/S transition and hepatoma growth by preventing DHX9-mediated CDK6 downregulation.
    Hepatology. 2019 Mar 13. doi: 10.1002/hep.30613.
    PubMed     Text format     Abstract available


  23. MA M, Xu H, Liu G, Wu J, et al
    MITA1, a novel energy stress-inducible lncRNA, promotes hepatocellular carcinoma metastasis.
    Hepatology. 2019 Mar 6. doi: 10.1002/hep.30602.
    PubMed     Text format     Abstract available


  24. HUANG Z, Wu LM, Zhang JL, Sabri A, et al
    DUSP12 Regulates Hepatic Lipid Metabolism through Inhibition of Lipogenesis and ASK1 Pathways.
    Hepatology. 2019 Mar 1. doi: 10.1002/hep.30597.
    PubMed     Text format     Abstract available


  25. MOUSA O, Malhi H, Schwartz RE, Kulai TB, et al
    Hepatology Highlights.
    Hepatology. 2019;69:927-930.
    PubMed     Text format    


    February 2019
  26. HUELIN P, Sola E, Elia C, Sole C, et al
    Neutrophil gelatinase-associated lipocalin for assessment of acute kidney injury in cirrhosis. A prospective study.
    Hepatology. 2019 Feb 27. doi: 10.1002/hep.30592.
    PubMed     Text format     Abstract available


  27. HARA K, Takeda A, Tsurugai Y, Saigusa Y, et al
    Radiotherapy for Hepatocellular Carcinoma Results in Comparable Survival to Radiofrequency Ablation: a Propensity Score Analysis.
    Hepatology. 2019 Feb 25. doi: 10.1002/hep.30591.
    PubMed     Text format     Abstract available


  28. HARRISON SA, Rossi SJ, Paredes AH, Trotter JF, et al
    NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients with Nonalcoholic Steatohepatitis.
    Hepatology. 2019 Feb 25. doi: 10.1002/hep.30590.
    PubMed     Text format     Abstract available


  29. WANG Y, Kory N, Cohen JC, Hobbs HH, et al
    PNPLA3, CGI-58, and Inhibition of Hepatic Triglyceride Hydrolysis in Mice.
    Hepatology. 2019 Feb 25. doi: 10.1002/hep.30583.
    PubMed     Text format     Abstract available


  30. TODESCA P, Marzi L, Critelli RM, Cuffari B, et al
    Angiopoietin-2/Tie2 inhibition by regorafenib associates with striking response in a patient with aggressive hepatocellular carcinoma.
    Hepatology. 2019 Feb 25. doi: 10.1002/hep.30588.
    PubMed     Text format     Abstract available


  31. RIMBAS RC, Rimbas M, Vinereanu D
    Echocardiographic Predictors of a Worse Outcome in Patients With Liver Cirrhosis: What Should We Assess?
    Hepatology. 2019 Feb 25. doi: 10.1002/hep.30584.
    PubMed     Text format     Abstract available


  32. WANG R, Zhu P
    Tuberculosis and anti-tuberculosis treatments cannot be ignored when evaluating cirrhotic patients co-infected with HIV or not.
    Hepatology. 2019 Feb 25. doi: 10.1002/hep.30582.
    PubMed     Text format     Abstract available


  33. KAPURIA D, Ben-Yakov G, Ortolano R, Ho-Cho M, et al
    The Spectrum of Hepatic Involvement in Patients with Telomere Disease.
    Hepatology. 2019 Feb 21. doi: 10.1002/hep.30578.
    PubMed     Text format     Abstract available


  34. MEHAL WZ, Loomba R
    The Intestinal Microbiome, Plasma Metabolome and Liver Transcriptome- A Conspiracy Driving Hepatic Steatosis.
    Hepatology. 2019 Feb 19. doi: 10.1002/hep.30577.
    PubMed     Text format     Abstract available


  35. WEN W, Schwabe RF
    Soluble fibers improve metabolic syndrome but may cause liver disease and hepatocellular carcinoma.
    Hepatology. 2019 Feb 14. doi: 10.1002/hep.30565.
    PubMed     Text format     Abstract available


  36. NGUYEN MH
    Hip fracture risk in patients with cirrhosis: does diabetes mellitus matter?
    Hepatology. 2019 Feb 14. doi: 10.1002/hep.30560.
    PubMed     Text format     Abstract available


  37. LAI SW, Lin CL
    Hip fracture risk in patients with cirrhosis: does diabetes mellitus matter?
    Hepatology. 2019 Feb 14. doi: 10.1002/hep.30566.
    PubMed     Text format     Abstract available


  38. CHIU V, Hogen R, Sher L, Wade N, et al
    Telomerase Variants in Patients with Cirrhosis Awaiting Liver Transplantation.
    Hepatology. 2019 Feb 14. doi: 10.1002/hep.30557.
    PubMed     Text format     Abstract available


  39. TONG J, Han CJ, Zhang JZ, He WZ, et al
    Hepatic IRF6 alleviates liver steatosis and metabolic disorder by transcriptionally suppressing PPARgamma.
    Hepatology. 2019 Feb 12. doi: 10.1002/hep.30559.
    PubMed     Text format     Abstract available


  40. QIAO Y, Wang J, Karagoz E, Liang B, et al
    Axin1 deletion induced hepatocarcinogenesis requires intact beta-Catenin but not Notch cascade in mice.
    Hepatology. 2019 Feb 8. doi: 10.1002/hep.30556.
    PubMed     Text format     Abstract available


  41. DEY P
    Carbon Tetrachloride (CCl4 )-Induced Classical Liver Cirrhosis Model: Revisiting The Mode Of Action.
    Hepatology. 2019 Feb 8. doi: 10.1002/hep.30555.
    PubMed     Text format     Abstract available


  42. ALBILLOS A, Munoz L, Alvarez-Mon M
    Reply to: Carbon Tetrachloride (CCl4)-Induced Classical Liver Cirrhosis Model: Revisiting The Mode Of Action.
    Hepatology. 2019 Feb 8. doi: 10.1002/hep.30554.
    PubMed     Text format     Abstract available


  43. TSANG FH, Law CT, Tang CT, Cheng CL, et al
    Aberrant super-enhancer landscape in human hepatocellular carcinoma.
    Hepatology. 2019 Feb 5. doi: 10.1002/hep.30544.
    PubMed     Text format     Abstract available


  44. MWANGI SM, Li G, Ye L, Liu Y, et al
    Glial Cell Line Derived Neurotrophic Factor Enhances Autophagic Flux in Mouse and Rat Hepatocytes and Protects Against Palmitate Lipotoxicity.
    Hepatology. 2019 Feb 4. doi: 10.1002/hep.30541.
    PubMed     Text format     Abstract available


  45. RUSSO N, Brown RS Jr, Shah SL, Krisko TI, et al
    Hepatology Highlights.
    Hepatology. 2019;69:469-472.
    PubMed     Text format    


    January 2019
  46. SHALIMAR, Sheikh MF, Mookerjee RP, Agarwal B, et al
    Prognostic Role of Ammonia in Cirrhotic Patients.
    Hepatology. 2019 Jan 31. doi: 10.1002/hep.30534.
    PubMed     Text format     Abstract available


  47. TAPPER EB
    Predicting Overt Hepatic Encephalopathy for the Population with Cirrhosis.
    Hepatology. 2019 Jan 31. doi: 10.1002/hep.30533.
    PubMed     Text format     Abstract available


  48. BAI L, Chen MM, Chen ZD, Zhang P, et al
    FBXW5 mediates the ubiquitination of ASK1 and exacerbates nonalcoholic steatohepatitis.
    Hepatology. 2019 Jan 31. doi: 10.1002/hep.30537.
    PubMed     Text format     Abstract available


  49. KIM D, Brocker CN, Takahashi S, Yagai T, et al
    Keratin 23 is a PPARA-dependent, MYC-amplified oncogene that promotes hepatocyte proliferation.
    Hepatology. 2019 Jan 29. doi: 10.1002/hep.30530.
    PubMed     Text format     Abstract available


  50. ZEUZEM S, Bourgeois S, Greenbloom S, Buti M, et al
    JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-infected Patients without Cirrhosis: OMEGA-1.
    Hepatology. 2019 Jan 28. doi: 10.1002/hep.30527.
    PubMed     Text format     Abstract available


  51. PORTA C, Broglia C, Negri F
    Medical treatment of advanced hepatocellular carcinoma patients: the issue is not the right drug, but the right patient.
    Hepatology. 2019 Jan 25. doi: 10.1002/hep.30521.
    PubMed     Text format     Abstract available


  52. WONG GL, Liang LY, Kwok R, Hui AJ, et al
    Low risk of variceal bleeding in cirrhotic patients after variceal screening stratified by liver/spleen stiffness.
    Hepatology. 2019 Jan 25. doi: 10.1002/hep.30522.
    PubMed     Text format     Abstract available


  53. YE X, Li C, Zu X, Lin M, et al
    A Large-Scale Multicenter Study Validates AKR1B10 as a New Prevalent Serum Marker for Detection of Hepatocellular Carcinoma.
    Hepatology. 2019 Jan 23. doi: 10.1002/hep.30519.
    PubMed     Text format     Abstract available


  54. PRATT DS
    Hepatology Elsewhere.
    Hepatology. 2019 Jan 23. doi: 10.1002/hep.30517.
    PubMed     Text format     Abstract available


  55. HASAN KM, Friedman TC, Shao X, Parveen M, et al
    E-cigarettes and Western Diet: Important Metabolic Risk Factors for Hepatic Diseases.
    Hepatology. 2019 Jan 21. doi: 10.1002/hep.30512.
    PubMed     Text format     Abstract available


  56. CAI J, Zhang XJ, Li H
    The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis.
    Hepatology. 2019 Jan 17. doi: 10.1002/hep.30506.
    PubMed     Text format     Abstract available


  57. ZHENG Y, Qu H, Xiong X, Wang Y, et al
    Deficiency of the mitochondrial glycerol 3-phosphate dehydrogenase contributes to hepatic steatosis.
    Hepatology. 2019 Jan 17. doi: 10.1002/hep.30507.
    PubMed     Text format     Abstract available


  58. CHEN H, Gao F, He M, Ding XF, et al
    Long-read RNA Sequencing identifies Novel Splice Variants in Hepatocellular Carcinoma and Tumor-specific Isoforms.
    Hepatology. 2019 Jan 13. doi: 10.1002/hep.30500.
    PubMed     Text format     Abstract available


  59. MAHMUD N, Kaplan DE, Taddei TH, Goldberg DS, et al
    Incidence and Mortality of Acute on Chronic Liver Failure using Two Definitions in Patients with Compensated Cirrhosis.
    Hepatology. 2019 Jan 7. doi: 10.1002/hep.30494.
    PubMed     Text format     Abstract available


  60. GOEPPERT B, Toth R, Singer S, Albrecht T, et al
    Integrative analysis defines distinct prognostic subgroups of intrahepatic cholangiocarcinoma.
    Hepatology. 2019 Jan 7. doi: 10.1002/hep.30493.
    PubMed     Text format     Abstract available


  61. RUSSO N, Jesudian A, Shen NT, Brown RS Jr, et al
    Hepatology Highlights.
    Hepatology. 2019;69:1-4.
    PubMed     Text format    


    December 2018
  62. KANWAL F, Tapper EB, Ho C, Asrani SK, et al
    Development of Quality Measures in Cirrhosis by the Practice Metrics Committee of the American Association for the Study of Liver Diseases.
    Hepatology. 2018 Dec 26. doi: 10.1002/hep.30489.
    PubMed     Text format     Abstract available


  63. SHIFFMAN ML, Sussman NL, Ravendhran N, Ditmyer M, et al
    Financial compensation for hepatologists in different practice settings.
    Hepatology. 2018 Dec 26. doi: 10.1002/hep.30488.
    PubMed     Text format     Abstract available


  64. MOORE A, Wu L, Chuang JC, Sun X, et al
    Arid1a loss drives non-alcoholic steatohepatitis in mice via epigenetic dysregulation of hepatic lipogenesis and fatty acid oxidation.
    Hepatology. 2018 Dec 25. doi: 10.1002/hep.30487.
    PubMed     Text format     Abstract available


  65. HUYNH H, Lee LY, Goh KY, Ong R, et al
    Infigratinib mediates vascular normalization, impairs metastasis and improves chemotherapy in hepatocellular carcinoma.
    Hepatology. 2018 Dec 21. doi: 10.1002/hep.30481.
    PubMed     Text format     Abstract available


  66. COTTER TG, Charlton M
    The Triumph of Bacchus: The Emergence of Nonalcoholic Steatohepatitis and Alcoholic Liver Disease as the Leading Causes of Mortality from Cirrhosis.
    Hepatology. 2018 Dec 20. doi: 10.1002/hep.30408.
    PubMed     Text format     Abstract available


  67. SALMON-CERON D, Nahon P, Layese R, Bourcier V, et al
    HIV/HCV co-infected cirrhotic patients are no longer at higher risk for HCC or end-stage liver disease as compared to HCV mono-infected patients.
    Hepatology. 2018 Dec 19. doi: 10.1002/hep.30400.
    PubMed     Text format     Abstract available


  68. CHEHADE S, Adams PC
    Severe hemochromatosis arthropathy in the absence of iron overload.
    Hepatology. 2018 Dec 18. doi: 10.1002/hep.30469.
    PubMed     Text format     Abstract available


  69. LEE D, Xu IM, Chiu DK, Leibold J, et al
    Induction of Oxidative Stress via Inhibition of Thioredoxin Reductase 1 is an Effective Therapeutic Approach for Hepatocellular Carcinoma.
    Hepatology. 2018 Dec 18. doi: 10.1002/hep.30467.
    PubMed     Text format     Abstract available


  70. RIVEIRO-BARCIELA M, Gironella M, Senin A, Salcedo MT, et al
    Decompensated liver disease due to primary hepatic amyloidosis: Is liver transplantation still mandatory?
    Hepatology. 2018 Dec 18. doi: 10.1002/hep.30464.
    PubMed     Text format     Abstract available


  71. ZUO X, Chen Z, Cai J, Gao W, et al
    5-hydroxytryptamine receptor 1D aggravates hepatocellular carcinoma progression via FoxO6 in AKT-dependent and independent manners.
    Hepatology. 2018 Dec 18. doi: 10.1002/hep.30430.
    PubMed     Text format     Abstract available


  72. YANG JD, Patel T
    Early Detection of Hepatocellular Carcinoma - Expanding the Utility of Circulating Tumor Markers.
    Hepatology. 2018 Dec 17. doi: 10.1002/hep.30468.
    PubMed     Text format     Abstract available


  73. UNZU C, Planet E, Brandenberg N, Fusil F, et al
    Pharmacological induction of a progenitor state for the efficient expansion of primary human hepatocytes.
    Hepatology. 2018 Dec 14. doi: 10.1002/hep.30425.
    PubMed     Text format     Abstract available


  74. MEHTA N, Dodge JL, Roberts JP, Hirose R, et al
    Alpha-fetoprotein Decrease from >1000 to <500 ng/ml in Patients with Hepatocellular Carcinoma Leads to Improved Post-Transplant Outcomes.
    Hepatology. 2018 Dec 13. doi: 10.1002/hep.30413.
    PubMed     Text format     Abstract available


  75. RAND EB
    Cirrhotic Cardiomyopathy in children with BA: A new objective parameter to predict morbidity and mortality on the waitlist - and beyond!
    Hepatology. 2018 Dec 12. doi: 10.1002/hep.30419.
    PubMed     Text format     Abstract available


  76. CLARIA J, Moreau R, Fenaille F, Amoros A, et al
    Orchestration of Tryptophan-Kynurenine pathway, acute decompensation and acute-on-chronic liver failure in cirrhosis.
    Hepatology. 2018 Dec 6. doi: 10.1002/hep.30363.
    PubMed     Text format     Abstract available


  77. HUANG L, Cai J, Guo H, Gu J, et al
    ID3 Promotes Stem Cell Features and Predicts Chemotherapeutic Response of Intrahepatic Cholangiocarcinoma.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30404.
    PubMed     Text format     Abstract available


  78. MO DC, Jia RR, Zhong JH
    Hepatic Resection Compared to Chemoembolization in Intermediate to Advanced-Stage HCC: a comment for moving forward.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30409.
    PubMed     Text format     Abstract available


  79. BALE R, Schullian P, Eberle G, Putzer D, et al
    Stereotactic radiofrequency ablation of hepatocellular carcinoma - A histopathological study in explanted livers.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30406.
    PubMed     Text format     Abstract available


  80. HUCK I, Gunewardena S, Espanol-Suner R, Willenbring H, et al
    Hepatocyte Nuclear Factor 4 alpha (HNF4alpha) Activation is Essential for Termination of Liver Regeneration.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30405.
    PubMed     Text format     Abstract available


  81. KHAMBU B, Li T, Yan S, Yu C, et al
    Hepatic Autophagy Deficiency Compromises FXR Functionality and Causes Cholestatic Injury.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30407.
    PubMed     Text format     Abstract available


  82. SIMONETTO DA, Piccolo Serafim L, Gallo de Moraes A, Gajic O, et al
    Management of Sepsis in Patients with Cirrhosis: current evidence and practical approach.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30412.
    PubMed     Text format     Abstract available


  83. LAW CT, Wei L, Tsang FH, Chan CY, et al
    HELLS regulates chromatin remodeling and epigenetic silencing of multiple tumor suppressor genes in human hepatocellular carcinoma.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30414.
    PubMed     Text format     Abstract available


  84. ALVES-BEZERRA M, Li Y, Acuna M, Ivanova AA, et al
    Thioesterase Superfamily Member 2 Promotes Hepatic VLDL Secretion by Channeling Fatty Acids into Triglyceride Biosynthesis.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30411.
    PubMed     Text format     Abstract available



  85. 2018 HEPATOLOGY Referees (Volumes 67 and 68).
    Hepatology. 2018;68:2446-2452.
    PubMed     Text format    


  86. SHEN NT, Brown RS Jr, Imai N, Krisko TI, et al
    Hepatology Highlights.
    Hepatology. 2018;68:2049-2052.
    PubMed     Text format    


  87. VILAR-GOMEZ E, Vuppalanchi R, Gawrieh S, Ghabril M, et al
    Vitamin E Improves Transplant-free Survival and Hepatic Decompensation among Patients with NASH and Advanced Fibrosis.
    Hepatology. 2018 Dec 1. doi: 10.1002/hep.30368.
    PubMed     Text format     Abstract available


  88. GIOIA S, Nardelli S, Riggio O
    Liver stiffness in non-cirrhotic portal hypertension - The Devil is in the diagnosis.
    Hepatology. 2018 Dec 1. doi: 10.1002/hep.30367.
    PubMed     Text format     Abstract available


  89. FANG JH, Xu L, Shang LR, Pan CZ, et al
    Vessels that encapsulate tumor clusters (VETC) pattern is a predictor of sorafenib benefit in patients with hepatocellular carcinoma.
    Hepatology. 2018 Dec 1. doi: 10.1002/hep.30366.
    PubMed     Text format     Abstract available


  90. MA Y, Yang W, Simon TG, Smith-Warner SA, et al
    Dietary patterns and risk of hepatocellular carcinoma among US men and women.
    Hepatology. 2018 Dec 1. doi: 10.1002/hep.30362.
    PubMed     Text format     Abstract available


  91. ARORA V, Sarin SK
    Reply.
    Hepatology. 2018;68:2444.
    PubMed     Text format    


  92. VERMA S, Agarwal S, Singh S, Pandey N, et al
    Letter To Editor: Terlipressin is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute On Chronic Liver Failure.
    Hepatology. 2018;68:2442-2443.
    PubMed     Text format    


  93. IMAI N, Cohen DE
    Trimming the Fat: Acetyl-CoA Carboxylase Inhibition for the Management of NAFLD.
    Hepatology. 2018;68:2062-2065.
    PubMed     Text format    


  94. BRENNER DA
    Of Mice and Men and Nonalcoholic Steatohepatitis.
    Hepatology. 2018;68:2059-2061.
    PubMed     Text format    


  95. KHADERI S, Sussman N, Kanwal F
    Project ECHO: The Specialist Will See You Now.
    Hepatology. 2018;68:2066-2068.
    PubMed     Text format    


  96. MIN JH, Kim JM, Kim YK, Kang TW, et al
    Prospective Intraindividual Comparison of Magnetic Resonance Imaging With Gadoxetic Acid and Extracellular Contrast for Diagnosis of Hepatocellular Carcinomas Using the Liver Imaging Reporting and Data System.
    Hepatology. 2018;68:2254-2266.
    PubMed     Text format     Abstract available


  97. LOPICCOLO J, Brener MI, Oshima K, Lipson EJ, et al
    Nodular Regenerative Hyperplasia Associated With Immune Checkpoint Blockade.
    Hepatology. 2018;68:2431-2433.
    PubMed     Text format    


  98. CALVOPINA DA, Chatfield MD, Weis A, Coleman MA, et al
    MicroRNA Sequencing Identifies a Serum MicroRNA Panel, Which Combined With Aspartate Aminotransferase to Platelet Ratio Index Can Detect and Monitor Liver Disease in Pediatric Cystic Fibrosis.
    Hepatology. 2018;68:2301-2316.
    PubMed     Text format     Abstract available


  99. ALLEN AM, Van Houten HK, Sangaralingham LR, Talwalkar JA, et al
    Healthcare Cost and Utilization in Nonalcoholic Fatty Liver Disease: Real-World Data From a Large U.S. Claims Database.
    Hepatology. 2018;68:2230-2238.
    PubMed     Text format     Abstract available


  100. GE X, Arriazu E, Magdaleno F, Antoine DJ, et al
    High Mobility Group Box-1 Drives Fibrosis Progression Signaling via the Receptor for Advanced Glycation End Products in Mice.
    Hepatology. 2018;68:2380-2404.
    PubMed     Text format     Abstract available


  101. SU GL, Glass L, Tapper EB, Van T, et al
    Virtual Consultations Through the Veterans Administration SCAN-ECHO Project Improves Survival for Veterans With Liver Disease.
    Hepatology. 2018;68:2317-2324.
    PubMed     Text format     Abstract available


  102. XU X, Krumm C, So JS, Bare CJ, et al
    Preemptive Activation of the Integrated Stress Response Protects Mice From Diet-Induced Obesity and Insulin Resistance by Fibroblast Growth Factor 21 Induction.
    Hepatology. 2018;68:2167-2181.
    PubMed     Text format     Abstract available


    November 2018
  103. NEONG SF, Billington EO, Congly SE
    Sexual dysfunction and sex hormone abnormalities in patients with cirrhosis: Review of pathogenesis and management.
    Hepatology. 2018 Nov 23. doi: 10.1002/hep.30359.
    PubMed     Text format     Abstract available


  104. MA Y, Belyaeva OV, Brown PM, Fujita K, et al
    HSD17B13 is a Hepatic Retinol Dehydrogenase Associated with Histological Features of Non-Alcoholic Fatty Liver Disease.
    Hepatology. 2018 Nov 11. doi: 10.1002/hep.30350.
    PubMed     Text format     Abstract available


  105. MUNOZ L, Borrero MJ, Ubeda M, Conde E, et al
    Intestinal immune dysregulation driven by dysbiosis promotes barrier disruption and bacterial translocation in rats with cirrhosis.
    Hepatology. 2018 Nov 10. doi: 10.1002/hep.30349.
    PubMed     Text format     Abstract available


  106. SUN H, Huang Q, Huang M, Wen H, et al
    Human CD96 correlates to NK cell exhaustion and predicts the prognosis of human hepatocellular carcinoma.
    Hepatology. 2018 Nov 8. doi: 10.1002/hep.30347.
    PubMed     Text format     Abstract available


  107. SHAHEEN AA, Swain MG
    Using proper methods to identify cirrhosis patients in administrative databases is crucial to correctly predict outcomes.
    Hepatology. 2018 Nov 1. doi: 10.1002/hep.30343.
    PubMed     Text format     Abstract available


  108. LABGAA I, Demartines N, Melloul E
    Surgical Resection vs. Transarterial Chemoembolization for Intermediate Stage Hepatocellular Carcinoma (BCLC-B): An Unsolved Question.
    Hepatology. 2018 Nov 1. doi: 10.1002/hep.30338.
    PubMed     Text format     Abstract available


  109. TAPPER EB, Baki J, Parikh ND, Lok AS, et al
    Frailty, Psychoactive Medications, and Cognitive Dysfunction are Associated with Poor Patient-Reported Outcomes in Cirrhosis.
    Hepatology. 2018 Nov 1. doi: 10.1002/hep.30336.
    PubMed     Text format     Abstract available


  110. WANG YH, Chuang YH, Wu CF, Jan MC, et al
    Smoking and Hepatitis B Virus-Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine Aminotransferase.
    Hepatology. 2018 Nov 1. doi: 10.1002/hep.30339.
    PubMed     Text format     Abstract available


  111. FLYNN MJ, Sayed AA, Sharma R, Siddique A, et al
    Challenges and opportunities in the clinical development of immune checkpoint inhibitors for hepatocellular carcinoma.
    Hepatology. 2018 Nov 1. doi: 10.1002/hep.30337.
    PubMed     Text format     Abstract available



  112. Hepatology Highlights.
    Hepatology. 2018;68:1665-1667.
    PubMed     Text format    


  113. O'LEARY JG, Rajender Reddy K, Wong F, Garcia-Tsao G, et al
    Reply.
    Hepatology. 2018;68:2046-2048.
    PubMed     Text format    


  114. CARDOSO FS
    Acute-on-Chronic Liver Failure defined by NACSELD: The Impact on Prognosis and Futility of Care.
    Hepatology. 2018;68:2046.
    PubMed     Text format    


  115. MUZYKANTOV VR, Brenner JS
    Vascular Immunotargeting: Take the Highway to the First Exit.
    Hepatology. 2018;68:1672-1674.
    PubMed     Text format    


  116. TARGHER G, Byrne CD
    Ad Libitum Mediterranean or Low-Fat Diets as Treatments for Nonalcoholic Fatty Liver Disease?
    Hepatology. 2018;68:1668-1671.
    PubMed     Text format    


  117. KORATALA A, Alquadan KF
    Diminishing Kidney Reserve and the "Pseudo"normal Creatinine.
    Hepatology. 2018;68:2045.
    PubMed     Text format    


  118. NOH JH, Gorospe M
    AKTions by Cytoplasmic lncRNA CASC9 Promote Hepatocellular Carcinoma Survival.
    Hepatology. 2018;68:1675-1677.
    PubMed     Text format    


  119. TUFONI M, Serena Ricci C, Zaccherini G
    A Case of Immune-Mediated Liver Injury Induced by Olaparib.
    Hepatology. 2018;68:2039-2041.
    PubMed     Text format    


  120. KLINGENBERG M, Gross M, Goyal A, Polycarpou-Schwarz M, et al
    The Long Noncoding RNA Cancer Susceptibility 9 and RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein L Form a Complex and Coregulate Genes Linked to AKT Signaling.
    Hepatology. 2018;68:1817-1832.
    PubMed     Text format     Abstract available


  121. WU R, Murali R, Kabe Y, French SW, et al
    Baicalein Targets GTPase-Mediated Autophagy to Eliminate Liver Tumor-Initiating Stem Cell-Like Cells Resistant to mTORC1 Inhibition.
    Hepatology. 2018;68:1726-1740.
    PubMed     Text format     Abstract available


  122. YU CJ, Wang QS, Wu MM, Song BL, et al
    TRUSS Exacerbates NAFLD Development by Promoting IkappaBalpha Degradation in Mice.
    Hepatology. 2018;68:1769-1785.
    PubMed     Text format     Abstract available


  123. KIM G, Lee SE, Lee YB, Jun JE, et al
    Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study.
    Hepatology. 2018;68:1755-1768.
    PubMed     Text format     Abstract available


    October 2018
  124. VITALE A, Farinati F, Borzio M, Trevisani F, et al
    The critical issue of restaging patients with hepatocellular carcinoma.
    Hepatology. 2018 Oct 30. doi: 10.1002/hep.30322.
    PubMed     Text format     Abstract available


  125. FARRELL G, Schattenberg JM, Leclercq I, Yeh MM, et al
    Mouse models of nonalcoholic steatohepatitis Towards optimization of their relevance to human NASH.
    Hepatology. 2018 Oct 29. doi: 10.1002/hep.30333.
    PubMed     Text format     Abstract available


  126. ASLAM A, Ishtiaq R, Lau DTY
    Commentary for Hepatology Elsewhere Timely administration of birth dose HBV vaccine may break the chain of perinatal transmission.
    Hepatology. 2018 Oct 29. doi: 10.1002/hep.30332.
    PubMed     Text format     Abstract available


  127. CASTRO NARRO GE, Gamboa Dominguez A, Consuelo Sanchez A, Salazar Martinez A, et al
    Combined Hepatocellular-Cholangiocarcinoma in a Patient with Cirrhosis due to Cholesteryl Ester Storage Disease.
    Hepatology. 2018 Oct 29. doi: 10.1002/hep.30331.
    PubMed     Text format     Abstract available


  128. KIM HL, An J, Park JA, Park SH, et al
    Magnetic Resonance Imaging Is Cost-Effective for Hepatocellular Carcinoma Surveillance in High Risk Patients with Cirrhosis.
    Hepatology. 2018 Oct 26. doi: 10.1002/hep.30330.
    PubMed     Text format     Abstract available


  129. FU Y, Urban DJ, Nani RR, Zhang YF, et al
    Glypican-3 Specific Antibody Drug Conjugates Targeting Hepatocellular Carcinoma.
    Hepatology. 2018 Oct 24. doi: 10.1002/hep.30326.
    PubMed     Text format     Abstract available


  130. HUO TI, Liu PH, Hsu CY
    Staging and restaging for hepatocellular carcinoma: Solution of confusion?
    Hepatology. 2018 Oct 24. doi: 10.1002/hep.30324.
    PubMed     Text format     Abstract available


  131. YAN J, Yao B, Kuang H, Yang X, et al
    Liraglutide, sitagliptin and insulin glargine added to metformin: the effect on body weight and intrahepatic lipid in patients with type 2 diabetes mellitus and NAFLD.
    Hepatology. 2018 Oct 19. doi: 10.1002/hep.30320.
    PubMed     Text format     Abstract available


  132. CHEN Y, Hao X, Sun R, Wei H, et al
    NK cell-derived IFN-gamma promotes hepatocellular carcinoma through EpCAM-EMT axis in hepatitis B virus transgenic mice.
    Hepatology. 2018 Oct 17. doi: 10.1002/hep.30317.
    PubMed     Text format     Abstract available


  133. BANALES JM, Inarrairaegui M, Arbelaiz A, Milkiewicz P, et al
    Serum metabolites as diagnostic biomarkers for cholangiocarcinoma, hepatocellular carcinoma and primary sclerosing cholangitis.
    Hepatology. 2018 Oct 16. doi: 10.1002/hep.30319.
    PubMed     Text format     Abstract available


  134. VENTURA-COTS M, Watts AE, Cruz-Lemini M, Shah ND, et al
    Colder weather and fewer sunlight hours increase alcohol consumption and alcoholic cirrhosis worldwide.
    Hepatology. 2018 Oct 16. doi: 10.1002/hep.30315.
    PubMed     Text format     Abstract available


  135. ABRALDES JG, Trebicka J, Chalasani N, D'Amico G, et al
    Prioritization of Therapeutic Targets and Trial Design in Cirrhotic Portal Hypertension.
    Hepatology. 2018 Oct 15. doi: 10.1002/hep.30314.
    PubMed     Text format     Abstract available


  136. KO E, Seo HW, Jung ES, Ju S, et al
    PI3Kdelta is a new therapeutic target in hepatocellular carcinoma.
    Hepatology. 2018 Oct 9. doi: 10.1002/hep.30307.
    PubMed     Text format     Abstract available


  137. PERUGORRIA MJ, Olaizola P, Banales JM
    Cholangiocyte-to-Hepatocyte Differentiation: a Context Dependent Process and an Opportunity for Regenerative Medicine.
    Hepatology. 2018 Oct 8. doi: 10.1002/hep.30305.
    PubMed     Text format     Abstract available


  138. NARDELLI S, Gioia S, Ridola L, Farcomeni A, et al
    Proton pump inhibitors are associated to minimal and overt hepatic encephalopathy and increase mortality in cirrhotics.
    Hepatology. 2018 Oct 5. doi: 10.1002/hep.30304.
    PubMed     Text format     Abstract available


  139. LAI SW
    Proton pump inhibitors use and risk of hepatocellular carcinoma.
    Hepatology. 2018 Oct 5. doi: 10.1002/hep.30302.
    PubMed     Text format     Abstract available


  140. BLANER WS
    Hepatic Stellate Cells (HSCs) and Retinoids: Towards A Much More Defined Relationship.
    Hepatology. 2018 Oct 4. doi: 10.1002/hep.30293.
    PubMed     Text format     Abstract available


  141. ZHANG T, Duan J, Zhang L, Li Z, et al
    LXRalpha Promotes Hepatosteatosis in Part via Activation of MicroRNA-378 Transcription and Inhibition of Ppargc1beta Expression.
    Hepatology. 2018 Oct 3. doi: 10.1002/hep.30301.
    PubMed     Text format     Abstract available



  142. Hepatology Highlights.
    Hepatology. 2018;68:1213-1216.
    PubMed     Text format    


  143. CHEN JF, Lin BL
    Reply.
    Hepatology. 2018;68:1661.
    PubMed     Text format    


  144. YANG Y, Feng Y, Zhao X, Wang L, et al
    A New Concept: Pre-HCC Disease.
    Hepatology. 2018;68:1662.
    PubMed     Text format    


  145. PANDEY S
    Association of Nonalcoholic Fatty Liver Disease With Relative Skeletal Muscle Mass: A Public Health Perspective.
    Hepatology. 2018;68:1657.
    PubMed     Text format    


  146. BAJAJ JS, Moreau R, Kamath PS, Vargas HE, et al
    Acute-on-Chronic Liver Failure: Getting Ready for Prime Time?
    Hepatology. 2018;68:1621-1632.
    PubMed     Text format     Abstract available


  147. TRICO D, Caprio S, Rosaria Umano G, Pierpont B, et al
    Metabolic Features of Nonalcoholic Fatty Liver (NAFL) in Obese Adolescents: Findings From a Multiethnic Cohort.
    Hepatology. 2018;68:1376-1390.
    PubMed     Text format     Abstract available


  148. GRAHAM RP, Lackner C, Terracciano L, Gonzalez-Cantu Y, et al
    Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1-PRKACA fusion.
    Hepatology. 2018;68:1441-1447.
    PubMed     Text format     Abstract available


  149. SALEM R, Gabr A, Riaz A, Mora R, et al
    Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience.
    Hepatology. 2018;68:1429-1440.
    PubMed     Text format     Abstract available


    September 2018
  150. SIRICA AE, Gores GJ, Groopman JD, Selaru FM, et al
    Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances.
    Hepatology. 2018 Sep 25. doi: 10.1002/hep.30289.
    PubMed     Text format     Abstract available


  151. WILKINSON PD, Delgado ER, Alencastro F, Leek MP, et al
    The polyploid state restricts hepatocyte proliferation and liver regeneration.
    Hepatology. 2018 Sep 23. doi: 10.1002/hep.30286.
    PubMed     Text format     Abstract available


  152. COSTENTIN CE, Bababekov YJ, Zhu AX, Yeh H, et al
    Is it time to reconsider the Milan Criteria for selecting patients with hepatocellular carcinoma for deceased-donor liver transplantation?
    Hepatology. 2018 Sep 19. doi: 10.1002/hep.30278.
    PubMed     Text format     Abstract available


  153. SATSANGI S
    Noradrenaline for hepatorenal syndrome in patients with acute-on chronic liver failure- Hope still remains!
    Hepatology. 2018 Sep 19. doi: 10.1002/hep.30283.
    PubMed     Text format     Abstract available


  154. VOLK M, Mellinger J, Bansal MB, Gellad ZF, et al
    A Roadmap for Value-Based Payment Models among Patients with Cirrhosis.
    Hepatology. 2018 Sep 18. doi: 10.1002/hep.30277.
    PubMed     Text format     Abstract available


  155. MUMTAZ K, Issak A, Porter K, Kelly S, et al
    Validation of Risk Score in Predicting Early Readmissions in Decompensated Cirrhotic patients: A Model Based on the Administrative Database.
    Hepatology. 2018 Sep 15. doi: 10.1002/hep.30274.
    PubMed     Text format     Abstract available


  156. RUSSELL JO, Lu WY, Okabe H, Abrams M, et al
    Hepatocyte-specific beta-catenin deletion during severe liver injury provokes cholangiocytes to differentiate into hepatocytes.
    Hepatology. 2018 Sep 14. doi: 10.1002/hep.30270.
    PubMed     Text format     Abstract available


  157. RAEVENS S, Colle I
    Why pulse oximetry is inaccurate in liver cirrhosis - ancient knowledge.
    Hepatology. 2018 Sep 8. doi: 10.1002/hep.30260.
    PubMed     Text format     Abstract available


  158. CAMPANI C, Guido M, Colagrande S, Bartoli F, et al
    A large rheumatoid nodule mimicking hepatic malignancy.
    Hepatology. 2018 Sep 8. doi: 10.1002/hep.30261.
    PubMed     Text format     Abstract available


  159. YOUNOSSI ZM, Tampi R, Priyadarshini M, Nader F, et al
    Burden of Illness and Economic Model for Patients with Non-Alcoholic Steatohepatitis (NASH) in the United States.
    Hepatology. 2018 Sep 4. doi: 10.1002/hep.30254.
    PubMed     Text format     Abstract available


  160. INZAUGARAT ME, Johnson CD, Holtmann TM, McGeough MD, et al
    NLRP3 inflammasome activation in hepatic stellate cells induces murine liver fibrosis.
    Hepatology. 2018 Sep 4. doi: 10.1002/hep.30252.
    PubMed     Text format     Abstract available


  161. YOUNOSSI Z, Tacke F, Arrese M, Sharma BC, et al
    Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis.
    Hepatology. 2018 Sep 4. doi: 10.1002/hep.30251.
    PubMed     Text format     Abstract available


  162. KAMATH B, Mack CL
    From hepatocyte to cholangiocyte: the remarkable potential of transdifferentiation to treat cholestatic diseases.
    Hepatology. 2018 Sep 4. doi: 10.1002/hep.30250.
    PubMed     Text format     Abstract available


  163. KAO WY, Su CW, Tan EC, Lee PC, et al
    Proton Pump Inhibitors and Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B or C.
    Hepatology. 2018 Sep 2. doi: 10.1002/hep.30247.
    PubMed     Text format     Abstract available


  164. BROWN RS JR, Schwartz RE
    Hepatology Highlights.
    Hepatology. 2018;68:795-797.
    PubMed     Text format    


  165. LO GH
    The Use of Steroid for Transcatheter Arterial Chemoembolization: To Relieve Symptoms or to Mask Adverse Events?
    Hepatology. 2018;68:1207.
    PubMed     Text format    


  166. FUJIWARA K, Yasui S, Yokosuka O, Oda S, et al
    A Role of Renal Replacement Therapy for Acute Liver Failure.
    Hepatology. 2018;68:1204.
    PubMed     Text format    


  167. CUMMINGS D, Ferstenberg R
    Recommendations for the Evaluation for Autoimmune Liver Disease in Nonalcoholic Fatty Liver Disease.
    Hepatology. 2018;68:1203.
    PubMed     Text format    


  168. LEWIS K, Takebe T
    Tumoroid a la carte: Path for personalization.
    Hepatology. 2018;68:1189-1191.
    PubMed     Text format    


  169. DENISOV EV, Perelmuter VM
    A fixed partial epithelial-mesenchymal transition (EMT) triggers carcinogenesis, whereas asymmetrical division of hybrid EMT cells drives cancer progression.
    Hepatology. 2018;68:807-810.
    PubMed     Text format    


  170. MATAK A, Lahiri P, Ford E, Pabst D, et al
    Stochastic phenotype switching leads to intratumor heterogeneity in human liver cancer.
    Hepatology. 2018;68:933-948.
    PubMed     Text format     Abstract available


  171. RANDALL MH, Stoermann M, Rockey DC
    A "Faux" Case of Acute Liver Failure in a 28-Year-Old Pregnant Woman.
    Hepatology. 2018;68:1200-1202.
    PubMed     Text format    


  172. YANG E, Peng L, Lee WM
    Multiple admissions for acetaminophen overdose: Acetaminophen frequent fliers, a new entity?
    Hepatology. 2018;68:1197-1199.
    PubMed     Text format    


  173. CHAPIN CA, Burn T, Meijome T, Loomes KM, et al
    Indeterminate pediatric acute liver failure is uniquely characterized by a CD103(+) CD8(+) T-cell infiltrate.
    Hepatology. 2018;68:1087-1100.
    PubMed     Text format     Abstract available


  174. LAN T, Li C, Yang G, Sun Y, et al
    Sphingosine kinase 1 promotes liver fibrosis by preventing miR-19b-3p-mediated inhibition of CCR2.
    Hepatology. 2018;68:1070-1086.
    PubMed     Text format     Abstract available


    August 2018
  175. KISIEL JB, Dukek BA, Kanipakam RVSR, Ghoz HM, et al
    Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical Validation.
    Hepatology. 2018 Aug 31. doi: 10.1002/hep.30244.
    PubMed     Text format     Abstract available


  176. MOTINO O, Frances DE, Casanova N, Fuertes-Agudo M, et al
    Protective role of hepatocyte cyclooxygenase-2 expression against liver ischemia-reperfusion injury in mice.
    Hepatology. 2018 Aug 29. doi: 10.1002/hep.30241.
    PubMed     Text format     Abstract available


  177. CHOI J, Kim GA, Han S, Lee W, et al
    Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early Stage Hepatocellular Carcinoma.
    Hepatology. 2018 Aug 28. doi: 10.1002/hep.30233.
    PubMed     Text format     Abstract available


  178. MANTOVANI S, Oliviero B, Lombardi A, Varchetta S, et al
    Deficient natural killer cell NKp30-mediated function and altered NCR3 splice variants in hepatocellular carcinoma.
    Hepatology. 2018 Aug 28. doi: 10.1002/hep.30235.
    PubMed     Text format     Abstract available


  179. MARETTI-MIRA AC, Wang X, Wang L, DeLeve LD, et al
    Incomplete differentiation of engrafted bone marrow endothelial progenitor cells initiates hepatic fibrosis in the rat.
    Hepatology. 2018 Aug 23. doi: 10.1002/hep.30227.
    PubMed     Text format     Abstract available


  180. ALLEGRETTI AS, Parada XV, Ortiz GA, Long J, et al
    Serum Angiopoietin-2 Predicts Mortality and Kidney Outcomes in Decompensated Cirrhosis.
    Hepatology. 2018 Aug 23. doi: 10.1002/hep.30230.
    PubMed     Text format     Abstract available


  181. LIGAT G, Schuster C, Baumert TF
    HBV core variants, liver fibrosis and hepatocellular carcinoma.
    Hepatology. 2018 Aug 23. doi: 10.1002/hep.30231.
    PubMed     Text format     Abstract available


  182. HLADY RA, Sathyanarayan A, Thompson JJ, Zhou D, et al
    Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma.
    Hepatology. 2018 Aug 22. doi: 10.1002/hep.30211.
    PubMed     Text format     Abstract available


  183. KO S, Monga SP
    Hepatic zonation now on hormones!
    Hepatology. 2018 Aug 18. doi: 10.1002/hep.30221.
    PubMed     Text format     Abstract available


  184. INADA Y, Mizukoshi E, Seike T, Tamai T, et al
    Characteristics of immune response to tumor-associated antigens and immune cell profile in hepatocellular carcinoma patients.
    Hepatology. 2018 Aug 13. doi: 10.1002/hep.30212.
    PubMed     Text format     Abstract available


  185. WANG X, Ribeiro M, Iracheta-Vellve A, Lowe P, et al
    Macrophage-specific HIF-1alpha contributes to impaired autophagic flux in non-alcoholic steatohepatitis.
    Hepatology. 2018 Aug 13. doi: 10.1002/hep.30215.
    PubMed     Text format     Abstract available


  186. GHALLAB A, Hofmann U, Sezgin S, Vartak N, et al
    Bile micro-infarcts in cholestasis are initiated by rupture of the apical hepatocyte membrane and cause shunting of bile to sinusoidal blood.
    Hepatology. 2018 Aug 13. doi: 10.1002/hep.30213.
    PubMed     Text format     Abstract available


  187. PANDEY S
    Letter to the Editor: The Genetic Architecture of Diet-induced Hepatic Fibrosis in Mice: A Public Health Perspective.
    Hepatology. 2018 Aug 4. doi: 10.1002/hep.30207.
    PubMed     Text format     Abstract available


  188. YANG L, Wang W, Wang X, Zhao J, et al
    CREG in Hepatocytes Ameliorates Liver Ischemia/Reperfusion Injury in a TAK1-Dependent Manner in Mice.
    Hepatology. 2018 Aug 4. doi: 10.1002/hep.30203.
    PubMed     Text format     Abstract available


  189. YKI-JARVINEN H
    Diabetes, liver cancer and cirrhosis: What next?
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30136.
    PubMed     Text format     Abstract available


  190. ALCARAZ-QUILES J, Casulleras M, Oettl K, Titos E, et al
    Oxidized albumin triggers a cytokine storm in leukocytes through p38 MAP kinase: role in systemic inflammation in decompensated cirrhosis.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30135.
    PubMed     Text format     Abstract available


  191. L'HERMITTE A, Pham S, Cadoux M, Couchy G, et al
    Lect2 controls inflammatory monocytes to constrain the growth and progression of hepatocellular carcinoma.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30140.
    PubMed     Text format     Abstract available


  192. LI CL, Li CY, Lin YY, Ho MC, et al
    Androgen Receptor Enhances Hepatic TERT Transcription after Hepatitis B Virus Integration or Point Mutation in Promoter Region.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30201.
    PubMed     Text format     Abstract available


  193. GANE EJ, Stedman CA, Schwabe C, Vijgen L, et al
    Short Duration AL-335, Odalasvir, With/Without Simeprevir, in Patients With HCV GT1 or 3 Infection Without Cirrhosis.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30126.
    PubMed     Text format     Abstract available


  194. LIU LZ, Zhang Z, Zheng BH, Shi Y, et al
    CCL15 recruits suppressive monocytes to facilitate immune escape and disease progression in hepatocellular carcinoma.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30134.
    PubMed     Text format     Abstract available


  195. FORDE KA, Fallon MB, Krowka MJ, Sprys M, et al
    Pulse Oximetry is Insensitive for Detection of Hepatopulmonary Syndrome in Patients evaluated for Liver Transplantation.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30139.
    PubMed     Text format     Abstract available


  196. YOUNOSSI ZM
    Patient-reported Outcomes and the Economic Effects of Non-Alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis - The Value Proposition.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30125.
    PubMed     Text format     Abstract available


  197. COTTON RT, Tran Cao HS, Rana AA, Sada YH, et al
    Impact of the Treating Hospital on Care Outcomes for Hepatocellular Carcinoma.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30128.
    PubMed     Text format     Abstract available


  198. DROLZ A, Horvatits T, Rutter K, Landahl F, et al
    Lactate improves prediction of short-term mortality in critically ill cirrhosis patients: a multinational study.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30151.
    PubMed     Text format     Abstract available


  199. SINGAL AG, Tiro JA, Murphy CC, Marrero JA, et al
    Mailed Outreach Invitations Significantly Improve HCC Surveillance Rates in Patients with Cirrhosis: A Randomized Clinical Trial.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30129.
    PubMed     Text format     Abstract available


  200. HLADY RA, Robertson KD
    A three-pronged epigenetic approach to the treatment of hepatocellular carcinoma.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30133.
    PubMed     Text format     Abstract available


  201. LIU J, Jiang J, Mo J, Liu D, et al
    Global DNA 5-hydroxymethylcytosine and 5-formylcytosine contents are decreased in the early stage of hepatocellular carcinoma.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30146.
    PubMed     Text format     Abstract available


  202. SHEN Y, Czaja MJ
    A Novel Mechanism of Starvation-Stimulated Hepatic Autophagy: Calcium-Induced O-GlcNAc-Dependent Signaling.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30118.
    PubMed     Text format     Abstract available


  203. SQUIRES JE, Rudnick DA, Hardison RM, Horslen S, et al
    Liver Transplant Listing in Pediatric Acute Liver Failure (PALF): Practices and Participant Characteristics.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30116.
    PubMed     Text format     Abstract available


  204. TAFESH ZH, Brown RS Jr, Russo N, Rosenblatt R, et al
    Hepatology Highlights.
    Hepatology. 2018;68:393-396.
    PubMed     Text format    


  205. DE MATTOS AZ, de Mattos AA
    Evaluating Prognosis of Patients With Acute-On-Chronic Liver Failure: Is the Simplest Score Good Enough?
    Hepatology. 2018;68:790.
    PubMed     Text format    


  206. O'LEARY JG, Rajender Reddy K, Wong F, Garcia-Tsao G, et al
    Reply.
    Hepatology. 2018;68:791.
    PubMed     Text format    


  207. PENG TC
    Role of Sarcopenia in Nonalcoholic Fatty Liver Disease: Definition Is Crucially Important.
    Hepatology. 2018;68:788-789.
    PubMed     Text format    


  208. GRETEN TF
    The ABC of adaptive immunity in liver cancer.
    Hepatology. 2018;68:777-779.
    PubMed     Text format    


  209. HUANG R, Gao ZH, Tang A, Sebastiani G, et al
    Transient elastography is an unreliable marker of liver fibrosis in patients with portal vein thrombosis.
    Hepatology. 2018;68:783-785.
    PubMed     Text format    


  210. MOEST W, van der Deure W, Koster T, Spee-Dropkova M, et al
    Glycogen storage disease type Ia: Adult presentation with microcytic anemia and liver adenomas.
    Hepatology. 2018;68:780-782.
    PubMed     Text format    


  211. DUAN JL, Ruan B, Yan XC, Liang L, et al
    Endothelial Notch activation reshapes the angiocrine of sinusoidal endothelia to aggravate liver fibrosis and blunt regeneration in mice.
    Hepatology. 2018;68:677-690.
    PubMed     Text format     Abstract available


  212. CAUSSY C, Reeder SB, Sirlin CB, Loomba R, et al
    Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials.
    Hepatology. 2018;68:763-772.
    PubMed     Text format     Abstract available


  213. WANGENSTEEN KJ, Wang YJ, Dou Z, Wang AW, et al
    Combinatorial genetics in liver repopulation and carcinogenesis with a in vivo CRISPR activation platform.
    Hepatology. 2018;68:663-676.
    PubMed     Text format     Abstract available


  214. LUDVIGSSON JF, Marschall HU, Hagstrom H, Hoijer J, et al
    Pregnancy outcome in women undergoing liver biopsy during pregnancy: A nationwide population-based cohort study.
    Hepatology. 2018;68:625-633.
    PubMed     Text format     Abstract available


    July 2018
  215. HERNANDEZ-GEA V, Baiges A, Turon F, Garcia-Pagan JC, et al
    Idiopathic Portal Hypertension.
    Hepatology. 2018 Jul 31. doi: 10.1002/hep.30132.
    PubMed     Text format     Abstract available


  216. GARCIA-TSAO G, Fuchs M, Shiffman M, Borg BB, et al
    Emricasan (IDN-6556) Lowers Portal Pressure in Patients with Compensated Cirrhosis and Severe Portal Hypertension.
    Hepatology. 2018 Jul 31. doi: 10.1002/hep.30199.
    PubMed     Text format     Abstract available


  217. CORTES E, Lachowski D, Rice A, Chronopoulos A, et al
    RAR-beta is downregulated in HCC & cirrhosis and its expression inhibits myosin-driven activation and durotaxis in hepatic stellate cells.
    Hepatology. 2018 Jul 28. doi: 10.1002/hep.30193.
    PubMed     Text format     Abstract available


  218. MAZZARELLI C, Cannon MD, Hudson M, Heaton N, et al
    Hepatocellular Carcinoma as a complication of vascular disease of the liver after Fontan procedure.
    Hepatology. 2018 Jul 28. doi: 10.1002/hep.30194.
    PubMed     Text format     Abstract available


  219. LI W, Li Y, Siraj S, Jin H, et al
    FUNDC1-mediated mitophagy suppresses hepatocarcinogenesis by inhibition of inflammasome activation.
    Hepatology. 2018 Jul 27. doi: 10.1002/hep.30191.
    PubMed     Text format     Abstract available


  220. RODERFELD M, Padem S, Lichtenberger J, Quack T, et al
    Schistosoma mansoni egg secreted antigens activate HCC-associated transcription factors c-Jun and STAT3 in hamster and human hepatocytes.
    Hepatology. 2018 Jul 27. doi: 10.1002/hep.30192.
    PubMed     Text format     Abstract available


  221. VITALE A, Farinati F, Noaro G, Burra P, et al
    Restaging patients with hepatocellular carcinoma before additional treatment decisions: a multicenter cohort study.
    Hepatology. 2018 Jul 26. doi: 10.1002/hep.30185.
    PubMed     Text format     Abstract available


  222. DIAZ-GONZALEZ A, Monclus E, Darnell A, Sole M, et al
    Liver metastases from gastric adenocarcinoma mimicking multinodular hepatocellular carcinoma.
    Hepatology. 2018 Jul 25. doi: 10.1002/hep.30120.
    PubMed     Text format     Abstract available


  223. ARAB JP, Arrese M
    "Old remedies to heal the liver: novel effects of digoxin in hepatic sterile inflammation".
    Hepatology. 2018 Jul 23. doi: 10.1002/hep.30188.
    PubMed     Text format     Abstract available


  224. HONG W, Zhang CZ, Lu SX, Zhang MF, et al
    A CCDC50 splice variant is modulated by SRSF3 and promotes hepatocellular carcinoma via the Ras signaling pathway.
    Hepatology. 2018 Jul 20. doi: 10.1002/hep.30147.
    PubMed     Text format     Abstract available


  225. ZHOU X, Wen Y, Tian Y, He M, et al
    Hsp90alpha-dependent Bclaf1 promotes hepatocellular carcinoma proliferation by regulating c-MYC mRNA stability.
    Hepatology. 2018 Jul 17. doi: 10.1002/hep.30172.
    PubMed     Text format     Abstract available


  226. VUPPALANCHI R, Mathur K, Pyko M, Samala N, et al
    Liver Stiffness Measurements in Patients with Non-cirrhotic Portal Hypertension - The Devil is In the Details.
    Hepatology. 2018 Jul 17. doi: 10.1002/hep.30167.
    PubMed     Text format     Abstract available


  227. ROMAN E, Gely C, Flavia M, Poca M, et al
    Patients with compensated cirrhosis are also at risk of falling.
    Hepatology. 2018 Jul 17. doi: 10.1002/hep.30180.
    PubMed     Text format     Abstract available


  228. NAVIN P, Hilscher M, Welle C, Mounajjed T, et al
    The Utility of MR Elastography to Differentiate Nodular Regenerative Hyperplasia from Cirrhosis.
    Hepatology. 2018 Jul 17. doi: 10.1002/hep.30175.
    PubMed     Text format     Abstract available


  229. LIAO SH, Su TH, Jeng YM, Liang PC, et al
    Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma.
    Hepatology. 2018 Jul 16. doi: 10.1002/hep.30162.
    PubMed     Text format     Abstract available


  230. CINGOLANI F, Czaja MJ
    Oxidized Albumin - a Trojan Horse for p38 MAPK-Mediated Inflammation in Decompensated Cirrhosis.
    Hepatology. 2018 Jul 16. doi: 10.1002/hep.30164.
    PubMed     Text format     Abstract available


  231. ZHANG J, Han C, Ungerleider N, Chen W, et al
    A novel TGF-beta and H19 signaling axis in tumor-initiating hepatocytes that regulates hepatic carcinogenesis.
    Hepatology. 2018 Jul 16. doi: 10.1002/hep.30153.
    PubMed     Text format     Abstract available


  232. BARCENA-VARELA M, Caruso S, Llerena S, Alvarez-Sola G, et al
    Dual targeting of histone methyltransferase G9a and DNA-methyltransferase 1 for the treatment of experimental hepatocellular carcinoma.
    Hepatology. 2018 Jul 16. doi: 10.1002/hep.30168.
    PubMed     Text format     Abstract available


  233. KIM D, Li AA, Perumpail BJ, Gadiparthi C, et al
    Changing Trends in Etiology- and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States.
    Hepatology. 2018 Jul 16. doi: 10.1002/hep.30161.
    PubMed     Text format     Abstract available


  234. HAIDER C, Hnat J, Wagner R, Huber H, et al
    Transforming Growth Factor-beta and Axl Induce CXCL5 and Neutrophil Recruitment in Hepatocellular Carcinoma.
    Hepatology. 2018 Jul 16. doi: 10.1002/hep.30166.
    PubMed     Text format     Abstract available


  235. RUSSO N, Brown RS Jr, Shen NT, Pisa JF, et al
    Hepatology highlights.
    Hepatology. 2018;68:1-3.
    PubMed     Text format    


  236. POLYZOS SA, Kountouras J, Anastasiadis S, Doulberis M, et al
    Nonalcoholic fatty liver disease: Is it time for combination treatment and a diabetes-like approach?
    Hepatology. 2018;68:389.
    PubMed     Text format    


  237. VERMA N, Singh A, Singh V
    Reply.
    Hepatology. 2018;68:388.
    PubMed     Text format    


  238. CARR RM
    Proton pump inhibitors, Enterococcus, and the liver, oh my!
    Hepatology. 2018;68:376-379.
    PubMed     Text format    


  239. ARMENGOL C, Cairo S
    Identification of theranostic biomarkers to improve the stratification of patients with pediatric liver cancer: Opportunities and challenges.
    Hepatology. 2018;68:10-12.
    PubMed     Text format    


  240. HERNAEZ R, Kanwal F, El-Serag HB
    Hepatocellular carcinoma screening is associated with survival benefit in silico but needs confirmation in an in vivo analysis.
    Hepatology. 2018;68:7-9.
    PubMed     Text format    


  241. BILL R, Montani M, Blum B, Dufour JF, et al
    Favorable response to mammalian target of rapamycin inhibition in a young patient with unresectable fibrolamellar carcinoma of the liver.
    Hepatology. 2018;68:384-386.
    PubMed     Text format    


  242. ORLIEN SMS, Sandven I, Berhe NB, Ismael NY, et al
    Khat chewing increases the risk for developing chronic liver disease: A hospital-based case-control study.
    Hepatology. 2018;68:248-257.
    PubMed     Text format     Abstract available


  243. CAI Y, Li H, Liu M, Pei Y, et al
    Disruption of adenosine 2A receptor exacerbates NAFLD through increasing inflammatory responses and SREBP1c activity.
    Hepatology. 2018;68:48-61.
    PubMed     Text format     Abstract available


    June 2018
  244. HUI ST, Kurt Z, Tuominen I, Norheim F, et al
    The Genetic Architecture of Diet-induced Hepatic Fibrosis in Mice.
    Hepatology. 2018 Jun 16. doi: 10.1002/hep.30113.
    PubMed     Text format     Abstract available


  245. HAYASHI S, Khan A, Simons BC, Homan C, et al
    A novel association between core mutations in hepatitis B virus genotype F1b and hepatocellular carcinoma in Alaskan Native People.
    Hepatology. 2018 Jun 12. doi: 10.1002/hep.30111.
    PubMed     Text format     Abstract available


  246. BHUSHAN B, Stoops JW, Mars WM, Orr A, et al
    TCPOBOP-induced hepatomegaly & hepatocyte proliferation is attenuated by combined disruption of MET & EGFR signaling.
    Hepatology. 2018 Jun 11. doi: 10.1002/hep.30109.
    PubMed     Text format     Abstract available


  247. CHINO F, Pollis KE, Choi S, Salama JK, et al
    Stereotactic Body Radiation Therapy-induced Abscopal Effect on Hepatocellular Carcinoma after Treatment for Lung Cancer: A Case Report.
    Hepatology. 2018 Jun 11. doi: 10.1002/hep.30100.
    PubMed     Text format    


  248. PELLICANO R, Durazzo M
    Upper GI bleeding in cirrhotic patients: Which method to search for Helicobacter pylori infection?
    Hepatology. 2018 Jun 11. doi: 10.1002/hep.30108.
    PubMed     Text format    


  249. RUSSO N, Brown RS Jr, Cohen-Mekelburg S, Schwartz RE, et al
    Hepatology Highlights.
    Hepatology. 2018;67:2065-2067.
    PubMed     Text format    


  250. HUO TI, Hsu CY, Liu PH
    Magic mirror on the wall: Which is the best biomarker for hepatocellular carcinoma?
    Hepatology. 2018;67:2482-2483.
    PubMed     Text format    


  251. DEAR JW
    New biomarkers for drug-induced liver injury.
    Hepatology. 2018;67:2480-2481.
    PubMed     Text format    


  252. ZHANG C, Song F
    Knockout of ULK1/2 protects against acetaminophen-induced acute liver injury independent of autophagy?
    Hepatology. 2018;67:2476-2477.
    PubMed     Text format    


  253. LAI S, Iwakiri Y
    Is miR-21 a potent target for liver fibrosis?
    Hepatology. 2018;67:2082-2084.
    PubMed     Text format    


  254. BELLENTANI S, Bedogni G, Tiribelli C
    Two drinks per day does not take your fatty liver away.
    Hepatology. 2018;67:2072-2073.
    PubMed     Text format    


  255. ZHAO Q, Tang X, Wu J
    The association between nonalcoholic fatty liver disease and metabolic comorbidities.
    Hepatology. 2018;67:2474.
    PubMed     Text format    


  256. ZHANG XJ, She ZG, Li H
    Time to step-up the fight against NAFLD.
    Hepatology. 2018;67:2068-2071.
    PubMed     Text format    


  257. SUN Y, Li TY, Song L, Zhang C, et al
    Liver-specific deficiency of unc-51 like kinase 1 and 2 protects mice from acetaminophen-induced liver injury.
    Hepatology. 2018;67:2397-2413.
    PubMed     Text format     Abstract available


  258. SUN W, Zhang Y, Wong KC, Liu K, et al
    Increased expression of GATA zinc finger domain containing 1 through gene amplification promotes liver cancer by directly inducing phosphatase of regenerating liver 3.
    Hepatology. 2018;67:2302-2319.
    PubMed     Text format     Abstract available


  259. CHEN M, Wei L, Law CT, Tsang FH, et al
    RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Hepatology. 2018;67:2254-2270.
    PubMed     Text format     Abstract available


  260. ABERG F, Helenius-Hietala J, Puukka P, Farkkila M, et al
    Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population.
    Hepatology. 2018;67:2141-2149.
    PubMed     Text format     Abstract available


    May 2018
  261. GOEDEKE L, Bates J, Vatner DF, Perry RJ, et al
    Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents.
    Hepatology. 2018 May 23. doi: 10.1002/hep.30097.
    PubMed     Text format     Abstract available


  262. BLASI A, Calvo A, Prado V, Reverter E, et al
    Coagulation failure in patients with Acute-on-Chronic Liver Failure (ACLF) and decompensated cirrhosis: beyond INR.
    Hepatology. 2018 May 23. doi: 10.1002/hep.30103.
    PubMed     Text format     Abstract available


  263. YAN J, Lei J, Chen L, Deng H, et al
    FAT10 overexpression disturbs WISP1 protein and mRNA expression to promote hepatocellular carcinoma progression.
    Hepatology. 2018 May 23. doi: 10.1002/hep.30105.
    PubMed     Text format     Abstract available


  264. SCHULZE RJ, McNiven MA
    Fasting Inhibits the Recruitment of Kinesin-1 to Lipid Droplets and Stalls Hepatic Triglyceride Secretion.
    Hepatology. 2018 May 23. doi: 10.1002/hep.30104.
    PubMed     Text format    


  265. LIU M, Zhang L, Li H, Hinoue T, et al
    Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor SGI-110 in Hepatocellular Carcinoma.
    Hepatology. 2018 May 18. doi: 10.1002/hep.30091.
    PubMed     Text format     Abstract available


  266. BAJAJ JS, Savidge T, Kassam ZA, Hylemon PB, et al
    Fecal Microbial Transplant for Antibiotic-Associated Disruption in Cirrhosis.
    Hepatology. 2018 May 18. doi: 10.1002/hep.30092.
    PubMed     Text format    


  267. MULLISH BH, McDonald JAK, Thursz MR, Marchesi JR, et al
    Antibiotic-Associated Disruption of Microbiota Composition and Function in Cirrhosis is Restored by Fecal Transplant.
    Hepatology. 2018 May 18. doi: 10.1002/hep.30090.
    PubMed     Text format    


  268. WRIGHT TL, Reddy KR
    Thomas D. Boyer, MD: A visionary hepatologist, investigator, mentor and colleague.
    Hepatology. 2018 May 12. doi: 10.1002/hep.30089.
    PubMed     Text format    


  269. SUN P, Lu YX, Cheng D, Zhang K, et al
    Monocyte chemoattractant protein-induced protein 1 targets hypoxia-inducible factor 1alpha to protect against hepatic ischemia/reperfusion injury.
    Hepatology. 2018 May 9. doi: 10.1002/hep.30086.
    PubMed     Text format     Abstract available


  270. WINKLER N, Strubing F, Gross W, Mier W, et al
    Phenomenon of endothelial antibody capture: Principles and potential for locoregional targeting of hepatic tumors.
    Hepatology. 2018 May 7. doi: 10.1002/hep.30072.
    PubMed     Text format     Abstract available


  271. PANG Y, Kartsonaki C, Turnbull I, Guo Y, et al
    Diabetes, plasma glucose and incidence of fatty liver, cirrhosis and liver cancer: A prospective study of 0.5 million people.
    Hepatology. 2018 May 7. doi: 10.1002/hep.30083.
    PubMed     Text format     Abstract available


  272. MANSKE K, Kallin N, Konig V, Schneider A, et al
    Outcome of anti-viral immunity in the liver is shaped by the level of antigen expressed in infected hepatocytes.
    Hepatology. 2018 May 5. doi: 10.1002/hep.30080.
    PubMed     Text format     Abstract available


  273. WANG C, Cheng Y, Zhang X, Li N, et al
    Vacuolar Protein Sorting 33B Is a Tumor Suppressor in Hepatocarcinogenesis.
    Hepatology. 2018 May 5. doi: 10.1002/hep.30077.
    PubMed     Text format     Abstract available


  274. GAO S, Silasi-Mansat R, Behar M, Lupu F, et al
    Excessive plasmin compromises hepatic sinusoidal vascular integrity after acetaminophen overdose.
    Hepatology. 2018 May 5. doi: 10.1002/hep.30070.
    PubMed     Text format     Abstract available


  275. RAEVENS S, Fallon MB
    Potential clinical targets in hepatopulmonary syndrome: lessons from experimental models.
    Hepatology. 2018 May 5. doi: 10.1002/hep.30079.
    PubMed     Text format     Abstract available


  276. SUN P, Zeng Q, Cheng D, Zhang K, et al
    Caspase Recruitment Domain Protein 6 protects against hepatic steatosis and insulin resistance by suppressing Ask1.
    Hepatology. 2018 May 5. doi: 10.1002/hep.30075.
    PubMed     Text format     Abstract available


  277. PROPERZI C, O'Sullivan TA, Sherriff JL, Ching HL, et al
    Ad libitum Mediterranean and Low Fat Diets both Significantly Reduce Hepatic Steatosis: a Randomized Controlled Trial.
    Hepatology. 2018 May 5. doi: 10.1002/hep.30076.
    PubMed     Text format     Abstract available


  278. COHEN-MEKELBURG S, Schwartz RE, Rosenblatt R, Brown RS Jr, et al
    Hepatology Highlights.
    Hepatology. 2018;67:1647-1650.
    PubMed     Text format    


  279. FAN H, Zhu JH
    A novel frailty index improves risk prediction of waitlist mortality over the model for end-stage liver disease score alone.
    Hepatology. 2018;67:2059.
    PubMed     Text format    


  280. ZATLOUKAL K
    Bringing the cell nucleus in the focus of NAFLD.
    Hepatology. 2018;67:1654-1656.
    PubMed     Text format    


  281. WANG L
    Mesenchymal stromal cells in treatment of acute-on-chronic liver failure.
    Hepatology. 2018;67:2056-2057.
    PubMed     Text format    


  282. MUSSO G, Gambino R
    Targeting mitochondrial pyruvate carrier in nonalcoholic steatohepatitis: Growing evidence and future challenges.
    Hepatology. 2018;67:2055.
    PubMed     Text format    


  283. SAHA B, Momen-Heravi F, Furi I, Kodys K, et al
    Extracellular vesicles from mice with alcoholic liver disease carry a distinct protein cargo and induce macrophage activation through heat shock protein 90.
    Hepatology. 2018;67:1986-2000.
    PubMed     Text format     Abstract available


  284. WIN S, Than TA, Zhang J, Oo C, et al
    New insights into the role and mechanism of c-Jun-N-terminal kinase signaling in the pathobiology of liver diseases.
    Hepatology. 2018;67:2013-2024.
    PubMed     Text format     Abstract available


  285. STRAVITZ RT, Ellerbe C, Durkalski V, Schilsky M, et al
    Bleeding complications in acute liver failure.
    Hepatology. 2018;67:1931-1942.
    PubMed     Text format     Abstract available


  286. QI X, Mendez-Sanchez N, Mancuso A, Romeiro FG, et al
    Who should receive endoscopic variceal ligation after recovering from acute variceal bleeding?
    Hepatology. 2018;67:2057-2058.
    PubMed     Text format    


  287. WAN S, Meyer AS, Weiler SME, Rupp C, et al
    Cytoplasmic localization of the cell polarity factor scribble supports liver tumor formation and tumor cell invasiveness.
    Hepatology. 2018;67:1842-1856.
    PubMed     Text format     Abstract available


  288. CHEN R, Zhu S, Fan XG, Wang H, et al
    High mobility group protein B1 controls liver cancer initiation through yes-associated protein -dependent aerobic glycolysis.
    Hepatology. 2018;67:1823-1841.
    PubMed     Text format     Abstract available


  289. SIDDIQUI MS, Harrison SA, Abdelmalek MF, Anstee QM, et al
    Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science.
    Hepatology. 2018;67:2001-2012.
    PubMed     Text format     Abstract available


  290. ALLEN AM, Therneau TM, Larson JJ, Coward A, et al
    Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year-community study.
    Hepatology. 2018;67:1726-1736.
    PubMed     Text format     Abstract available


  291. BRADY GF, Kwan R, Ulintz PJ, Nguyen P, et al
    Nuclear lamina genetic variants, including a truncated LAP2, in twins and siblings with nonalcoholic fatty liver disease.
    Hepatology. 2018;67:1710-1725.
    PubMed     Text format     Abstract available


    April 2018
  292. LIANG Q, Liu Z, Zhu C, Wang B, et al
    Intrahepatic T cell receptor beta immune repertoire is essential for liver regeneration.
    Hepatology. 2018 Apr 27. doi: 10.1002/hep.30067.
    PubMed     Text format     Abstract available


  293. ALAO H, Cam M, Keembiyehetty C, Zhang F, et al
    Baseline Intrahepatic and Peripheral Innate Immunity are Associated with Hepatitis C Virus Clearance During DAA Therapy.
    Hepatology. 2018 Apr 27. doi: 10.1002/hep.29921.
    PubMed     Text format     Abstract available


  294. YIN Y, Xu X, Tang J, Zhang W, et al
    CD97 Promotes Tumor Aggressiveness through the Traditional G Protein-Coupled Receptor-mediated signaling in Hepatocellular Carcinoma.
    Hepatology. 2018 Apr 27. doi: 10.1002/hep.30068.
    PubMed     Text format     Abstract available


  295. CULLARO G, Park M, Lai JC
    "Normal" Creatinine Levels Predict Persistent Kidney Injury and Waitlist Mortality in Outpatients with Cirrhosis.
    Hepatology. 2018 Apr 26. doi: 10.1002/hep.30058.
    PubMed     Text format     Abstract available


  296. TAYLOR AE, Carey AN, Kudira R, Lages CS, et al
    Interleukin 2 promotes hepatic regulatory T cell responses and protects from biliary fibrosis in murine sclerosing cholangitis.
    Hepatology. 2018 Apr 26. doi: 10.1002/hep.30061.
    PubMed     Text format     Abstract available


  297. LUO P, Qin C, Zhu L, Fang C, et al
    Ubiquitin-specific Peptidase 10 (USP10) Inhibits Hepatic Steatosis, Insulin Resistance and Inflammation via Sirt6.
    Hepatology. 2018 Apr 26. doi: 10.1002/hep.30062.
    PubMed     Text format     Abstract available


  298. YANG JD, Gores GJ
    Does Cirrhosis Associated with Well Controlled Viral Hepatitis Confer a Risk for Extrahepatic Cancer?
    Hepatology. 2018 Apr 26. doi: 10.1002/hep.30063.
    PubMed     Text format    


  299. VERRIER ER, Yim SA, Heydmann L, El Saghire H, et al
    Hepatitis B virus evasion from cGAS sensing in human hepatocytes.
    Hepatology. 2018 Apr 20. doi: 10.1002/hep.30054.
    PubMed     Text format     Abstract available


  300. IZZY M, Oh J, Watt KD
    Cirrhotic cardiomyopathy after transplantation: Neither the transient nor innocent bystander.
    Hepatology. 2018 Apr 19. doi: 10.1002/hep.30040.
    PubMed     Text format     Abstract available


  301. KWONG AJ, Kim WR, Flemming JA
    De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era.
    Hepatology. 2018 Apr 19. doi: 10.1002/hep.30045.
    PubMed     Text format     Abstract available


  302. KO E, Kim JS, Ju S, Seo HW, et al
    Oxidatively modified PDIA3 promotes DKC1-mediated malignancy and survival of hepatocellular carcinoma cells.
    Hepatology. 2018 Apr 19. doi: 10.1002/hep.30039.
    PubMed     Text format     Abstract available


  303. LEMMER A, Van-Wagner LB, Ganger D
    Assessment of Advanced Liver Fibrosis and the Risk for Hepatic Decompensation in Patients with Congestive Hepatopathy.
    Hepatology. 2018 Apr 19. doi: 10.1002/hep.30048.
    PubMed     Text format     Abstract available


  304. PONZIANI FR, Bhoori S, Castelli C, Putignani L, et al
    Hepatocellular Carcinoma is Associated with Gut Microbiota Profile and Inflammation in Non-Alcoholic Fatty Liver Disease.
    Hepatology. 2018 Apr 17. doi: 10.1002/hep.30036.
    PubMed     Text format     Abstract available


  305. BAJAJ JS, Kakiyama G, Savidge T, Takei H, et al
    Antibiotic-Associated Disruption of Microbiota Composition and Function in Cirrhosis is Restored by Fecal Transplant.
    Hepatology. 2018 Apr 17. doi: 10.1002/hep.30037.
    PubMed     Text format     Abstract available


  306. MARRONE G, De Chiara F, Bottcher K, Levi A, et al
    The AMPK-v-ATPase-pH axis: A key regulator of the pro-fibrogenic phenotype of human hepatic stellate cells.
    Hepatology. 2018 Apr 17. doi: 10.1002/hep.30029.
    PubMed     Text format     Abstract available


  307. ALLAIRE M, Nahon P, Layese R, Bourcier V, et al
    Extra hepatic cancers are the leading cause of death in cirrhotic patients achieving HBV control or HCV eradication.
    Hepatology. 2018 Apr 16. doi: 10.1002/hep.30034.
    PubMed     Text format     Abstract available


  308. WANG C, Tong Y, Wen Y, Cai J, et al
    Hepatocellular Carcinoma-associated Protein TD26 Interacts and Enhances SREBP1 Activity to Promote Tumor Cell Proliferation and Growth.
    Hepatology. 2018 Apr 16. doi: 10.1002/hep.30030.
    PubMed     Text format     Abstract available


  309. VAN GOLEN RF, Reiniers MJ, van Gorp J, Tushuizen ME, et al
    Utilizing mechanistic biomarkers in treating paracetamol hepatotoxicity.
    Hepatology. 2018 Apr 16. doi: 10.1002/hep.30028.
    PubMed     Text format    


  310. WOO HG, Kim YJ
    Multi-platform genomic roadmap of hepatocellular carcinoma: A matter of molecular heterogeneity.
    Hepatology. 2018 Apr 10. doi: 10.1002/hep.29925.
    PubMed     Text format    


  311. WENDUM D, Layese R, Ganne-Carrie N, Bourcier V, et al
    Influence of progenitor-derived regeneration markers on HCV-related cirrhosis outcome (ANRS CO12 CirVir cohort).
    Hepatology. 2018 Apr 10. doi: 10.1002/hep.29927.
    PubMed     Text format     Abstract available


  312. ZHANG F, Hu Z, Li G, Huo S, et al
    Hepatic CREBZF Couples Insulin to Lipogenesis by Inhibiting Insig activity and Contributes to Hepatic Steatosis in Diet-Induced Insulin-Resistant Mice.
    Hepatology. 2018 Apr 10. doi: 10.1002/hep.29926.
    PubMed     Text format     Abstract available


  313. FANG JH, Zhang ZJ, Shang LR, Luo YW, et al
    Hepatoma cell-secreted exosomal microRNA-103 increases vascular permeability and promotes metastasis by targeting junction proteins.
    Hepatology. 2018 Apr 10. doi: 10.1002/hep.29920.
    PubMed     Text format     Abstract available


  314. LI H, Feng D, Cai Y, Liu Y, et al
    Hepatocytes and neutrophils cooperatively suppress bacterial infection by differentially regulating lipocalin-2 and NETs.
    Hepatology. 2018 Apr 10. doi: 10.1002/hep.29919.
    PubMed     Text format     Abstract available


  315. XIE L, Yin J, Xia R, Zhuang G, et al
    Cost-effectiveness of antiviral treatment after resection in HBV-related hepatocellular carcinoma patients with compensated cirrhosis.
    Hepatology. 2018 Apr 7. doi: 10.1002/hep.29922.
    PubMed     Text format     Abstract available


  316. CLOYD JM, Pawlik TM
    Diagnostic and Therapeutic Implications of Novel Peptides in Hepatocellular Carcinoma.
    Hepatology. 2018 Apr 7. doi: 10.1002/hep.29923.
    PubMed     Text format    


  317. MARRERO JA, Kulik LM, Sirlin C, Zhu AX, et al
    Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.
    Hepatology. 2018 Apr 6. doi: 10.1002/hep.29913.
    PubMed     Text format    


  318. VARGA ZV, Erdelyi K, Paloczi J, Cinar R, et al
    Disruption of renal arginine metabolism promotes kidney injury in hepatorenal syndrome.
    Hepatology. 2018 Apr 6. doi: 10.1002/hep.29915.
    PubMed     Text format     Abstract available


  319. VAN DER WINDT DJ, Sud V, Zhang H, Varley PR, et al
    Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in non-alcoholic steatohepatitis.
    Hepatology. 2018 Apr 6. doi: 10.1002/hep.29914.
    PubMed     Text format     Abstract available


  320. NIEC R, Schwartz RE, Rosenblatt R, Gupta V, et al
    Hepatology Highlights.
    Hepatology. 2018;67:1195-1197.
    PubMed     Text format    


  321. RABIEE A, Hamilton JPA
    Pregnancy in Wilson disease.
    Hepatology. 2018;67:1201-1203.
    PubMed     Text format    


  322. STARLINGER P, Pereyra D, Haegele S, Braeuer P, et al
    Perioperative von Willebrand factor dynamics are associated with liver regeneration and predict outcome after liver resection.
    Hepatology. 2018;67:1516-1530.
    PubMed     Text format     Abstract available


  323. WOO BAIDAL JA, Cheng ER, Rifas-Shiman SL, Oken E, et al
    Association of vitamin E intake at early childhood with alanine aminotransferase levels at mid-childhood.
    Hepatology. 2018;67:1339-1347.
    PubMed     Text format     Abstract available


  324. PFEIFFENBERGER J, Beinhardt S, Gotthardt DN, Haag N, et al
    Pregnancy in Wilson's disease: Management and outcome.
    Hepatology. 2018;67:1261-1269.
    PubMed     Text format     Abstract available


    March 2018
  325. FIRL DJ, Kimura S, McVey J, Hashimoto K, et al
    Reframing the approach to patients with hepatocellular carcinoma: Longitudinal assessment with HALTHCC improves ablate and wait strategy.
    Hepatology. 2018 Mar 31. doi: 10.1002/hep.29907.
    PubMed     Text format     Abstract available


  326. BHANJI RA, Watt KD
    Reply to letter to the editor: "Sarcopenia in hiding: the risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis".
    Hepatology. 2018 Mar 31. doi: 10.1002/hep.29908.
    PubMed     Text format    


  327. FAILLACI F, Marzi L, Critelli R, Milosa F, et al
    Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals.
    Hepatology. 2018 Mar 31. doi: 10.1002/hep.29911.
    PubMed     Text format     Abstract available


  328. HOFMANN AF, Marschall HU
    Plasma Bile Acid Concentrations in Humans: Suggestions for Presentation in Tabular Form.
    Hepatology. 2018 Mar 31. doi: 10.1002/hep.29909.
    PubMed     Text format    


  329. KUREBAYASHI Y, Ojima H, Tsujikawa H, Kubota N, et al
    Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification.
    Hepatology. 2018 Mar 30. doi: 10.1002/hep.29904.
    PubMed     Text format     Abstract available


  330. PAYANCE A, Silva-Junior G, Bissonnette J, Tanguy M, et al
    Hepatocyte microvesicle levels improve prediction of mortality in patients with cirrhosis.
    Hepatology. 2018 Mar 30. doi: 10.1002/hep.29903.
    PubMed     Text format     Abstract available


  331. WU J, Zhao Y, Park YK, Lee JY, et al
    Loss of PDK4 switches the hepatic NF-kappaB/TNF pathway from pro-survival to pro-apoptosis.
    Hepatology. 2018 Mar 30. doi: 10.1002/hep.29902.
    PubMed     Text format     Abstract available


  332. YOUNOSSI ZM
    Reply letter to the editor: Combination Therapy for Non-alcoholic Steatohepatitis (NASH).
    Hepatology. 2018 Mar 30. doi: 10.1002/hep.29896.
    PubMed     Text format    


  333. MELLINGER JL, Shedden K, Winder GS, Tapper E, et al
    The High Burden of Alcoholic Cirrhosis in Privately Insured Persons in the United States.
    Hepatology. 2018 Mar 26. doi: 10.1002/hep.29887.
    PubMed     Text format     Abstract available


  334. SLIJEPCEVIC D, Roscam Abbing RLP, Fuchs CD, Haazen LCM, et al
    NTCP inhibition has hepatoprotective effects in cholestasis in mice.
    Hepatology. 2018 Mar 24. doi: 10.1002/hep.29888.
    PubMed     Text format     Abstract available


  335. NAULT JC, Couchy G, Caruso S, Meunier L, et al
    ASS1 and peri-portal gene expression in sonic hedgehog hepatocellular adenomas.
    Hepatology. 2018 Mar 24. doi: 10.1002/hep.29884.
    PubMed     Text format     Abstract available


  336. GUO JT, Block TM
    Do hepatitis B surface antigens have any role in viral carcinogenesis?
    Hepatology. 2018 Mar 24. doi: 10.1002/hep.29886.
    PubMed     Text format    


  337. CAUSSY C, Hsu C, Lo MT, Liu A, et al
    Novel link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD.
    Hepatology. 2018 Mar 23. doi: 10.1002/hep.29892.
    PubMed     Text format     Abstract available


  338. CHEN Z, Gao W, Pu L, Zhang L, et al
    PRDM8 Exhibits Anti-Tumor Activities Toward Hepatocellular Carcinoma by Targeting NAP1L1.
    Hepatology. 2018 Mar 23. doi: 10.1002/hep.29890.
    PubMed     Text format     Abstract available


  339. HYUN MH, Lee YS, Kim JH, Lee CU, et al
    Hepatic Resection Compared to Chemoembolization in Intermediate to Advanced Stage Hepatocellular Carcinoma: A Meta-analysis of High-Quality Studies.
    Hepatology. 2018 Mar 15. doi: 10.1002/hep.29883.
    PubMed     Text format     Abstract available


  340. VANWAGNER LB, Kanwal F
    Hepatology in a Changing Health Care Landscape: A Call for Health Services Research.
    Hepatology. 2018 Mar 14. doi: 10.1002/hep.29880.
    PubMed     Text format     Abstract available


  341. FUNG J, Cheung KS, Wong DK, Mak LY, et al
    Long Term Outcomes and Predictive Scores for Hepatocellular Carcinoma and HBsAg Seroclearance after HBeAg Seroclearance.
    Hepatology. 2018 Mar 13. doi: 10.1002/hep.29874.
    PubMed     Text format     Abstract available


  342. ZHANG D, Tong X, Nelson BB, Jin E, et al
    The hepatic BMAL1/AKT/Lipogenesis axis protects against alcoholic liver disease via promoting PPARalpha pathway.
    Hepatology. 2018 Mar 13. doi: 10.1002/hep.29878.
    PubMed     Text format     Abstract available


  343. MOYLAN CA, Abdelmalek MF
    Nonalcoholic Fatty Liver Disease with Cirrhosis Increases Familial Risk for Advanced Fibrosis.
    Hepatology. 2018 Mar 13. doi: 10.1002/hep.29879.
    PubMed     Text format    


  344. WU Y, Shan B, Dai J, Xia Z, et al
    Dual Role for Inositol-requiring Enzyme 1alpha in Promoting the Development of Hepatocellular Carcinoma during Diet-induced Obesity.
    Hepatology. 2018 Mar 5. doi: 10.1002/hep.29871.
    PubMed     Text format     Abstract available


  345. PHILIPS CA, Augustine P, Mathew S, Valiathan GC, et al
    Letter to the editor: Growth factor therapy for decompensated cirrhosis - Much ado about nothing?
    Hepatology. 2018 Mar 3. doi: 10.1002/hep.29866.
    PubMed     Text format    


  346. ZHANG XP, Wang K, Guo WX, Chen ZH, et al
    Is sorafenib an optimal treatment for hepatocellular carcinoma with macrovascular invasion or metastatic disease?
    Hepatology. 2018 Mar 3. doi: 10.1002/hep.29862.
    PubMed     Text format    


  347. ROSENBLATT R, Brown RS Jr., Mukewar S, Schneider Y, et al
    Hepatology Highlights.
    Hepatology. 2018;67:817-819.
    PubMed     Text format    


  348. ABERG F
    Liver fibrosis scores in the general population: Better risk indices are needed!
    Hepatology. 2018;67:1186.
    PubMed     Text format    


  349. SOOKOIAN S, Pirola CJ
    The nonalcoholic steatohepatitis metabotype: Imbalance of circulating amino acids and transamination reactions reflect impaired mitochondrial function.
    Hepatology. 2018;67:1177-1178.
    PubMed     Text format    


  350. BRAILLON A
    Adding care to cure for patients with liver disease: A cultural shift.
    Hepatology. 2018;67:1172.
    PubMed     Text format    


  351. STRAVITZ RT, Gottfried M, Durkalski V, Fontana RJ, et al
    Safety, tolerability, and pharmacokinetics of l-ornithine phenylacetate in patients with acute liver injury/failure and hyperammonemia.
    Hepatology. 2018;67:1003-1013.
    PubMed     Text format     Abstract available


    February 2018
  352. HENEGHAN MA, Cannon MD
    Hepatic diagnostics in pregnancy: Biopsy, biomarkers and beyond.
    Hepatology. 2018 Feb 27. doi: 10.1002/hep.29859.
    PubMed     Text format    


  353. WU JF, Lee CS, Lin WH, Jeng YM, et al
    Transient elastography is useful in diagnosing biliary atresia and predicting prognosis after hepatoportoenterostomy.
    Hepatology. 2018 Feb 27. doi: 10.1002/hep.29856.
    PubMed     Text format     Abstract available


  354. HUANG AC, Mehta N, Dodge JL, Yao FY, et al
    Direct-acting Antivirals Do Not Increase the Risk of Hepatocellular Carcinoma Recurrence after Local-Regional Therapy or Liver Transplant Waitlist Dropout.
    Hepatology. 2018 Feb 24. doi: 10.1002/hep.29855.
    PubMed     Text format     Abstract available


  355. FOSTER GR, Agarwal K, Cramp ME, Moreea S, et al
    Elbasvir/Grazoprevir and Sofosbuvir for HCV Genotype 3 Infection With Compensated Cirrhosis: A Randomized Trial.
    Hepatology. 2018 Feb 23. doi: 10.1002/hep.29852.
    PubMed     Text format     Abstract available


  356. LEBEAUPIN C, Vallee D, Rousseau D, Patouraux S, et al
    Bax Inhibitor-1 protects from Non-Alcoholic Steatohepatitis by limiting IRE1alpha signaling.
    Hepatology. 2018 Feb 19. doi: 10.1002/hep.29847.
    PubMed     Text format     Abstract available


  357. CHEN H, Shen F, Sherban A, Nocon A, et al
    DEPTOR Suppresses Lipogenesis and Ameliorates Hepatic Steatosis and Acute-on-Chronic Liver Injury in Alcoholic Liver Disease.
    Hepatology. 2018 Feb 19. doi: 10.1002/hep.29849.
    PubMed     Text format     Abstract available


  358. ZAMORA-VALDES D, Watt KD, Kellogg TA, Poterucha JJ, et al
    Long-term outcomes of patients undergoing simultaneous Liver Transplantation and Sleeve Gastrectomy.
    Hepatology. 2018 Feb 19. doi: 10.1002/hep.29848.
    PubMed     Text format     Abstract available


  359. CAREY W
    Statin Use In Cirrhosis from Fatty Liver Disease.
    Hepatology. 2018 Feb 14. doi: 10.1002/hep.29842.
    PubMed     Text format    


  360. ZHU W, Peng Y, Wang L, Hong Y, et al
    Identification of alpha-fetoprotein-specific T cell receptors for hepatocellular carcinoma immunotherapy.
    Hepatology. 2018 Feb 14. doi: 10.1002/hep.29844.
    PubMed     Text format     Abstract available


  361. MAZZAFERRO V, Droz Dit Busset M, Bhoori S
    Alpha-Fetoprotein (AFP) in liver transplantation for HCC: The lower, the better.
    Hepatology. 2018 Feb 9. doi: 10.1002/hep.29835.
    PubMed     Text format    


  362. KLEINER DE
    Hepatocellular Carcinoma: Liver Biopsy in the Balance.
    Hepatology. 2018 Feb 5. doi: 10.1002/hep.29831.
    PubMed     Text format     Abstract available


  363. JING R, Zhou X, Zhao J, Wei Y, et al
    Fluorescent peptide highlights micronodules in murine hepatocellular carcinoma models and human in vitro.
    Hepatology. 2018 Feb 5. doi: 10.1002/hep.29829.
    PubMed     Text format     Abstract available


  364. WANG M, Ju C
    Orchestrating liver repair - a newly discovered function of hepatic iNKT cells.
    Hepatology. 2018 Feb 5. doi: 10.1002/hep.29828.
    PubMed     Text format    


  365. OLAIZOLA P, Perugorria MJ, Banales JM
    Towards Personalized Medicine for Intrahepatic Cholangiocarcinoma: Pharmacogenomic Stratification of Patients.
    Hepatology. 2018 Feb 2. doi: 10.1002/hep.29830.
    PubMed     Text format    


    January 2018
  366. JUN G, Fang C, Zhang P, Wang PX, et al
    Tumor progression locus 2 in hepatocytes potentiates both liver and systemic metabolic disorders.
    Hepatology. 2018 Jan 30. doi: 10.1002/hep.29820.
    PubMed     Text format     Abstract available


  367. PU W, Li J, Zheng Y, Shen X, et al
    Targeting Pin1 by inhibitor API-1 regulates microRNA biogenesis and suppresses hepatocellular carcinoma development.
    Hepatology. 2018 Jan 30. doi: 10.1002/hep.29819.
    PubMed     Text format     Abstract available


  368. RIDOLA L, Riggio O
    Prediction of Hepatic Encephalopathy: Why disregard well known risk factors?
    Hepatology. 2018 Jan 29. doi: 10.1002/hep.29808.
    PubMed     Text format    


  369. LIU X, Guo GL, Kong B, Hilburn DB, et al
    Farnesoid X Receptor Signaling Activates the Hepatic X-box Binding Protein 1 Pathway in vitro and in Mice.
    Hepatology. 2018 Jan 29. doi: 10.1002/hep.29815.
    PubMed     Text format     Abstract available


  370. TAPPER EB, Ratz D, Lok AS, Su GL, et al
    Re: Prediction of Hepatic Encephalopathy: why disregard well known risk factors?
    Hepatology. 2018 Jan 24. doi: 10.1002/hep.29806.
    PubMed     Text format    


  371. KOSTALLARI E, Hirsova P, Prasnicka A, Verma VK, et al
    Hepatic stellate cell-derived PDGFRalpha-enriched extracellular vesicles promote liver fibrosis in mice through SHP2.
    Hepatology. 2018 Jan 23. doi: 10.1002/hep.29803.
    PubMed     Text format     Abstract available


  372. BRUNT E, Aishima S, Clavien PA, Fowler K, et al
    cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation.
    Hepatology. 2018 Jan 23. doi: 10.1002/hep.29789.
    PubMed     Text format     Abstract available


  373. BERZIGOTTI A, Bosch J
    Reply to "Balancing exercise-induced weight loss with protein caloric requirement remains a challenge in overweight patients with cirrhosis".
    Hepatology. 2018 Jan 22. doi: 10.1002/hep.29799.
    PubMed     Text format    


  374. DHALIWAL A, Towey J, Haydon G, Elsharkawy AM, et al
    Balancing exercise-induced weight loss with protein caloric requirement remains a challenge in overweight patients with cirrhosis.
    Hepatology. 2018 Jan 22. doi: 10.1002/hep.29801.
    PubMed     Text format    


  375. WANG X, Du H, Shao S, Bo T, et al
    Cyclophilin D Deficiency Attenuates Mitochondrial Perturbation and Ameliorates Hepatic Steatosis.
    Hepatology. 2018 Jan 21. doi: 10.1002/hep.29788.
    PubMed     Text format     Abstract available


  376. LO GH
    Does antiplatelet therapy really reduce the risk of hepatocellular carcinoma in hepatitis B patients with antiviral drug?
    Hepatology. 2018 Jan 21. doi: 10.1002/hep.29794.
    PubMed     Text format    


  377. LU M, Wu J, Hao ZW, Shang YK, et al
    Basolateral CD147 Induces Hepatocyte Polarity Loss by E-cadherin Ubiquitination and Degradation in Hepatocellular Carcinoma Progress.
    Hepatology. 2018 Jan 21. doi: 10.1002/hep.29798.
    PubMed     Text format     Abstract available


  378. FERNANDEZ M
    Placental Growth Factor: New Treatment Target Bringing Hope in Hepatopulmonary Syndrome.
    Hepatology. 2018 Jan 21. doi: 10.1002/hep.29795.
    PubMed     Text format    


  379. WANG X, Zhang M, Ping F, Liu H, et al
    Identification and Therapeutic Intervention of Co-activated ALK, FGFR2 and EphA5 Kinases in Hepatocellular Carcinoma.
    Hepatology. 2018 Jan 21. doi: 10.1002/hep.29792.
    PubMed     Text format     Abstract available


  380. YEN CJ, Ai YL, Tsai HW, Chan SH, et al
    Hepatitis B virus surface gene pre-S2 mutant as a high-risk serum marker for hepatoma recurrence after curative hepatic resection.
    Hepatology. 2018 Jan 19. doi: 10.1002/hep.29790.
    PubMed     Text format     Abstract available


  381. KAGEYAMA S, Nakamura K, Fujii T, Ke B, et al
    Recombinant Relaxin Protects Liver Transplants from Ischemia Damage via Hepatocyte Glucocorticoid Receptor: From Bench-to-Bedside.
    Hepatology. 2018 Jan 19. doi: 10.1002/hep.29787.
    PubMed     Text format     Abstract available


  382. BAJAJ JS, Idilman R, Mabudian L, Hood M, et al
    Diet Affects Gut Microbiota and Modulates Hospitalization Risk Differentially In an International Cirrhosis Cohort.
    Hepatology. 2018 Jan 19. doi: 10.1002/hep.29791.
    PubMed     Text format     Abstract available


  383. ZHAO Z, Xu D, Wang Z, Wang L, et al
    Hepatic PPARalpha function is controlled by polyubiquitination and proteasome-mediated degradation via the coordinated actions of PAQR3 and HUWE1.
    Hepatology. 2018 Jan 13. doi: 10.1002/hep.29786.
    PubMed     Text format     Abstract available


  384. GULAMHUSEIN AF, Lazaridis KN
    Primary Biliary Cholangitis, DNA and Beyond: The Relative Contribution of Genes.
    Hepatology. 2018 Jan 13. doi: 10.1002/hep.29783.
    PubMed     Text format    


  385. WU SY, Lan SH, Wu SR, Chiu YC, et al
    Hepatocellular carcinoma-related cyclin D1 is selectively regulated by autophagy degradation system.
    Hepatology. 2018 Jan 12. doi: 10.1002/hep.29781.
    PubMed     Text format     Abstract available


  386. BOTTCHER K, Rombouts K, Saffioti F, Roccarina D, et al
    MAIT cells are chronically activated in patients with autoimmune liver disease and promote pro-fibrogenic hepatic stellate cell activation.
    Hepatology. 2018 Jan 12. doi: 10.1002/hep.29782.
    PubMed     Text format     Abstract available


  387. ZHENG H, Pomyen Y, Hernandez MO, Li C, et al
    Single cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma.
    Hepatology. 2018 Jan 9. doi: 10.1002/hep.29778.
    PubMed     Text format     Abstract available


  388. PATIDAR KR, Kang L, Bajaj JS, Carl D, et al
    Fractional excretion of urea: A simple tool for the differential diagnosis of acute kidney injury in cirrhosis.
    Hepatology. 2018 Jan 8. doi: 10.1002/hep.29772.
    PubMed     Text format     Abstract available


  389. O'LEARY JG, Reddy KR, Garcia-Tsao G, Biggins SW, et al
    NACSELD Acute-on-Chronic Liver Failure (NACSELD-ACLF) Score Predicts 30-Day Survival in Hospitalized Patients with Cirrhosis.
    Hepatology. 2018 Jan 8. doi: 10.1002/hep.29773.
    PubMed     Text format     Abstract available


  390. PALARIA A, Angelo JR, Guertin T, Mager J, et al
    Patterning of the hepato-pancreatobiliary boundary by BMP reveals heterogeneity within the murine liver bud.
    Hepatology. 2018 Jan 5. doi: 10.1002/hep.29769.
    PubMed     Text format     Abstract available


  391. NOVIKOV A, Schwartz RE, Mukewar S, Brown RS Jr, et al
    Hepatology Highlights.
    Hepatology. 2018;67:1-3.
    PubMed     Text format    


  392. VUPPALANCHI R, Siddiqui MS, Van Natta ML, Hallinan E, et al
    Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease.
    Hepatology. 2018;67:134-144.
    PubMed     Text format     Abstract available


  393. GAGGINI M, Carli F, Rosso C, Buzzigoli E, et al
    Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance.
    Hepatology. 2018;67:145-158.
    PubMed     Text format     Abstract available


  394. ESTES C, Razavi H, Loomba R, Younossi Z, et al
    Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.
    Hepatology. 2018;67:123-133.
    PubMed     Text format     Abstract available


  395. ZHANG J, Li Z, Liu L, Wang Q, et al
    Long noncoding RNA TSLNC8 is a tumor suppressor that inactivates the interleukin-6/STAT3 signaling pathway.
    Hepatology. 2018;67:171-187.
    PubMed     Text format     Abstract available


  396. AYONRINDE OT, Adams LA, Mori TA, Beilin LJ, et al
    Sex differences between parental pregnancy characteristics and nonalcoholic fatty liver disease in adolescents.
    Hepatology. 2018;67:108-122.
    PubMed     Text format     Abstract available


  397. WREE A, Inzaugarat ME, Feldstein AE
    Transmembrane BAX Inhibitor motif-containing 1, a novel anti-inflammatory approach for nonalcoholic steatohepatitis treatment.
    Hepatology. 2018;67:438-441.
    PubMed     Text format    


  398. SINGH S, Loomba R
    Role of two-dimensional shear wave elastography in the assessment of chronic liver diseases.
    Hepatology. 2018;67:13-15.
    PubMed     Text format    


  399. SARKAR M, Baffy G
    Perinatal programming of adolescent nonalcoholic fatty liver disease: A case for gender inequality?
    Hepatology. 2018;67:7-9.
    PubMed     Text format    


  400. CHALASANI N, Younossi Z, Lavine JE, Charlton M, et al
    The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.
    Hepatology. 2018;67:328-357.
    PubMed     Text format    


    December 2017
  401. ZIOL M, Pote N, Amaddeo G, Laurent A, et al
    Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance.
    Hepatology. 2017 Dec 27. doi: 10.1002/hep.29762.
    PubMed     Text format     Abstract available


  402. VERMA N, Kaur A, Sharma R, Bhalla A, et al
    Outcomes after Multiple courses of Granulocyte-Colony Stimulating Factor and Growth Hormone in Decompensated Cirrhosis: Randomized Trial.
    Hepatology. 2017 Dec 26. doi: 10.1002/hep.29763.
    PubMed     Text format     Abstract available


  403. NEPAL C, O'Rourke CJ, Oliveira DV, Taranta A, et al
    Genomic Perturbations Reveal Distinct Regulatory Networks in Intrahepatic Cholangiocarcinoma.
    Hepatology. 2017 Dec 26. doi: 10.1002/hep.29764.
    PubMed     Text format     Abstract available


  404. TAPPER EB, Kanwal F, Asrani SK, Ho C, et al
    Patient Reported Outcomes in Cirrhosis: A Scoping Review of the Literature.
    Hepatology. 2017 Dec 22. doi: 10.1002/hep.29756.
    PubMed     Text format     Abstract available


  405. YOSHIHARA T, Sakamori R, Furuta K, Shigekawa M, et al
    Hepatocellular Carcinoma Due to a Baffle Obstruction After the Mustard Operation: A Case Report.
    Hepatology. 2017 Dec 22. doi: 10.1002/hep.29758.
    PubMed     Text format     Abstract available


  406. WINTER A, Daures JP, Landais P
    Intention-to-treat survival benefit in liver transplantation: comments on Lai et al.
    Hepatology. 2017 Dec 22. doi: 10.1002/hep.29755.
    PubMed     Text format    


  407. BAJAJ JS, Hylemon PB
    Gut-Liver Axis Alterations in Alcoholic Liver Disease: Are Bile Acids the Answer?
    Hepatology. 2017 Dec 22. doi: 10.1002/hep.29760.
    PubMed     Text format    


  408. MORELLO E, Sutti S, Foglia B, Novo E, et al
    Hypoxia-inducible factor 2alpha drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine rich glycoprotein.
    Hepatology. 2017 Dec 21. doi: 10.1002/hep.29754.
    PubMed     Text format     Abstract available


  409. KIM DY, Han KH
    Staging for hepatocellular carcinoma in light of tumor heterogeneity: Time to change or update?
    Hepatology. 2017 Dec 21. doi: 10.1002/hep.29748.
    PubMed     Text format    


  410. SO J, Khaliq M, Evason K, Ninov N, et al
    Wnt/beta-catenin signaling controls intrahepatic biliary network formation in zebrafish by regulating Notch activity.
    Hepatology. 2017 Dec 21. doi: 10.1002/hep.29752.
    PubMed     Text format     Abstract available


  411. TAPPER EB, Lok AS, Su GL
    Re: Risk stratification of suffering hepatic encephalopathy in liver cirrhosis patients: novel strategy with novel concerns.
    Hepatology. 2017 Dec 21. doi: 10.1002/hep.29746.
    PubMed     Text format    


  412. ZHENG B, Zhu YJ, Jeong S, Wang HY, et al
    Risk stratification ofhepatic encephalopathy in liver cirrhosis patients: Novel strategy with novel concerns.
    Hepatology. 2017 Dec 21. doi: 10.1002/hep.29747.
    PubMed     Text format    


  413. CHO CS, Park HW, Ho A, Semple IA, et al
    Lipotoxicity induces hepatic protein inclusions through TBK1-mediated p62/SQSTM1 phosphorylation.
    Hepatology. 2017 Dec 18. doi: 10.1002/hep.29742.
    PubMed     Text format     Abstract available


  414. ZOU X, Ramachandran P, Kendall TJ, Pellicoro A, et al
    11betaHSD1 deficiency or inhibition enhances hepatic myofibroblast activation in murine liver fibrosis.
    Hepatology. 2017 Dec 18. doi: 10.1002/hep.29734.
    PubMed     Text format     Abstract available


  415. SHAN Z, Liu X, Chen Y, Wang M, et al
    Chitinase 3-like-1 Promotes Intrahepatic Activation of Coagulation Through Induction of Tissue Factor in Mice.
    Hepatology. 2017 Dec 18. doi: 10.1002/hep.29733.
    PubMed     Text format     Abstract available


  416. KIM E, Kim D, Lee JS, Yoe J, et al
    Capicua suppresses hepatocellular carcinoma progression by controlling ETV4-MMP1 axis.
    Hepatology. 2017 Dec 18. doi: 10.1002/hep.29738.
    PubMed     Text format     Abstract available


  417. SU TH, Tseng TC, Kao JH
    HCC risk in patients with HBV-related cirrhosis receiving NA therapy: is HCC prevented or delayed?
    Hepatology. 2017 Dec 18. doi: 10.1002/hep.29740.
    PubMed     Text format    


  418. SPELIOTES EK
    Thwart your destiny; effect of NAFLD genes on steatosis, liver injury and cirrhosis varies by body mass index.
    Hepatology. 2017 Dec 18. doi: 10.1002/hep.29739.
    PubMed     Text format    


  419. BRISEBOIS A, Ismond KP, Carbonneau M, Tandon P, et al
    Advance Care Planning (ACP) for specialists managing cirrhosis: a focus on patient-centered care.
    Hepatology. 2017 Dec 18. doi: 10.1002/hep.29731.
    PubMed     Text format     Abstract available


  420. ALI AH, Tabibian JH, Naser-Ghodsi N, Lennon RJ, et al
    Surveillance for Hepatobiliary Cancers in Patients with Primary Sclerosing Cholangitis.
    Hepatology. 2017 Dec 15. doi: 10.1002/hep.29730.
    PubMed     Text format     Abstract available


  421. QVARTSKHAVA N DR, Jin CJ Dr, Gorg B Dr, Haussinger D Prof Dr, et al
    Comment on Haakvort et al. 2017, Hepatology 65:281-293.
    Hepatology. 2017 Dec 12. doi: 10.1002/hep.29727.
    PubMed     Text format    


  422. GARCIA-TSAO G
    Regression of HCV cirrhosis: Time will tell.
    Hepatology. 2017 Dec 9. doi: 10.1002/hep.29720.
    PubMed     Text format    


  423. YOUNOSSI ZM, Loomba R, Anstee QM, Rinella ME, et al
    Diagnostic Modalities for Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH) and Associated Fibrosis.
    Hepatology. 2017 Dec 9. doi: 10.1002/hep.29721.
    PubMed     Text format     Abstract available


  424. TAPPER EB, Loomba R
    NAFLD, Metabolic Syndrome, and the Fight That Will Define Clinical Practice for a Generation of Hepatologists.
    Hepatology. 2017 Dec 9. doi: 10.1002/hep.29722.
    PubMed     Text format    


  425. YOUNOSSI ZM, Loomba R, Rinella ME, Bugianesi E, et al
    Current and Future Therapeutic Regimens for Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH).
    Hepatology. 2017 Dec 9. doi: 10.1002/hep.29724.
    PubMed     Text format     Abstract available


  426. LEVY C
    Evolving role of Obeticholic acid in primary biliary cholangitis.
    Hepatology. 2017 Dec 9. doi: 10.1002/hep.29726.
    PubMed     Text format    


  427. PINATO DJ
    Breaking Kuhn's paradigm in advanced hepatocellular carcinoma.
    Hepatology. 2017 Dec 8. doi: 10.1002/hep.29714.
    PubMed     Text format    


  428. ZHANG H, Li X, Yang Y, Zhang Y, et al
    Significance and Mechanism of Androgen Receptor (AR) Overexpression and AR-mTOR Crosstalk in Hepatocellular Carcinoma.
    Hepatology. 2017 Dec 8. doi: 10.1002/hep.29715.
    PubMed     Text format     Abstract available


  429. MURILLO PEREZ F, Goet JC, Lammers WJ, Gulamhusein A, et al
    Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history.
    Hepatology. 2017 Dec 8. doi: 10.1002/hep.29717.
    PubMed     Text format     Abstract available


  430. MASYUK TV, Masyuk AI, LaRusso NF
    Polycystic Liver Disease: The interplay of genes causative for hepatic and renal cystogenesis.
    Hepatology. 2017 Dec 6. doi: 10.1002/hep.29708.
    PubMed     Text format    


  431. VAN DE GRAAF S, Slijepcevic D
    Reply to D Levy - HEPATOLOGY.
    Hepatology. 2017 Dec 6. doi: 10.1002/hep.29709.
    PubMed     Text format    


  432. LEVY D
    The role of mEH, NTCP and OATP in hepatic sodium-dependent bile acid transport.
    Hepatology. 2017 Dec 6. doi: 10.1002/hep.29712.
    PubMed     Text format    


  433. KAKABADZE Z, Kakabadze A, Chakhunashvili D, Karalashvili L, et al
    Decellularized human placenta supports hepatic tissue and allows rescue in acute liver failure.
    Hepatology. 2017 Dec 6. doi: 10.1002/hep.29713.
    PubMed     Text format     Abstract available


  434. LI DK, Ren Y, Fierer DS, Rutledge S, et al
    The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: An ERCHIVES study.
    Hepatology. 2017 Dec 2. doi: 10.1002/hep.29707.
    PubMed     Text format     Abstract available



  435. 2017 Hepatology referees (volumes 65 and 66).
    Hepatology. 2017;66:2096-2101.
    PubMed     Text format    


  436. TOW C, Brown RS Jr, Tafesh ZH, Schwartz RE, et al
    Hepatology Highlights.
    Hepatology. 2017;66:1709-1712.
    PubMed     Text format    


  437. BHANJI RA, Narayanan P, Allen AM, Malhi H, et al
    Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis.
    Hepatology. 2017;66:2055-2065.
    PubMed     Text format     Abstract available


  438. PETTA S, Valenti L, Tuttolomondo A, Dongiovanni P, et al
    Interferon lambda 4 rs368234815 TT>deltaG variant is associated with liver damage in patients with nonalcoholic fatty liver disease.
    Hepatology. 2017;66:1885-1893.
    PubMed     Text format     Abstract available


  439. HU Y, Shin DJ, Pan H, Lin Z, et al
    YAP suppresses gluconeogenic gene expression through PGC1alpha.
    Hepatology. 2017;66:2029-2041.
    PubMed     Text format     Abstract available


  440. LI XF, Chen C, Xiang DM, Qu L, et al
    Chronic inflammation-elicited liver progenitor cell conversion to liver cancer stem cell with clinical significance.
    Hepatology. 2017;66:1934-1951.
    PubMed     Text format     Abstract available


  441. AUGUSTIN S, Pons M, Maurice JB, Bureau C, et al
    Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease.
    Hepatology. 2017;66:1980-1988.
    PubMed     Text format     Abstract available


  442. SORIA A, Lapadula G, Fabbiani M, Gori A, et al
    Lower effectiveness of hepatitis C antiviral treatment in patients with hepatocellular carcinoma: Is active tumor the clue?
    Hepatology. 2017 Dec 1. doi: 10.1002/hep.29700.
    PubMed     Text format    


  443. JI F, Yeo YH, Wei MT, Wei B, et al
    Hepatocellular carcinoma decreases the effectiveness of hepatitis C antiviral treatment: does direct-acting antiviral regimens matter?
    Hepatology. 2017 Dec 1. doi: 10.1002/hep.29701.
    PubMed     Text format    


  444. LIU X, Green RM
    Beyond Farnesoid X receptor to target new therapies for NAFLD.
    Hepatology. 2017;66:1724-1726.
    PubMed     Text format    


  445. WANG C, Bernards R
    In vivo veritas: Finding novel genes involved in liver cancer through in vivo genetic screens.
    Hepatology. 2017;66:2078-2080.
    PubMed     Text format    


    November 2017
  446. SINGH AK, Rooge SB, Varshney A, Vasudevan M, et al
    Global micro RNA expression profiling in the liver biopsies of Hepatitis B Virus infected patients suggests specific miRNA signatures for viral persistence and hepatocellular injury.
    Hepatology. 2017 Nov 30. doi: 10.1002/hep.29690.
    PubMed     Text format     Abstract available


  447. CHANG FM, Wang YP, Lu CL
    Reply: Statins decrease the risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: A population-based study.
    Hepatology. 2017 Nov 24. doi: 10.1002/hep.29686.
    PubMed     Text format    


  448. LIN CY
    Statins and risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: Methodological issues.
    Hepatology. 2017 Nov 24. doi: 10.1002/hep.29687.
    PubMed     Text format    


  449. LO GH, Reiberger T
    Peptic ulcer bleeding in cirrhotic patients: Is as bad as variceal bleeding?
    Hepatology. 2017 Nov 23. doi: 10.1002/hep.29680.
    PubMed     Text format     Abstract available


  450. ZHANG J, Zhang Q, Lou Y, Fu Q, et al
    HIF-1alpha/IL-1beta signaling enhances hepatoma epithelial-mesenchymal transition via macrophages in a hypoxic-inflammatory microenvironment.
    Hepatology. 2017 Nov 23. doi: 10.1002/hep.29681.
    PubMed     Text format     Abstract available


  451. PENG JM, Bera R, Chiou CY, Yu MC, et al
    Actin cytoskeleton remodeling drives epithelial-mesenchymal transition for hepatoma invasion and metastasis.
    Hepatology. 2017 Nov 23. doi: 10.1002/hep.29678.
    PubMed     Text format     Abstract available


  452. BORZIO M, Dionigi E, Rossini A, Marignani M, et al
    External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort study. (HEP-17-0903).
    Hepatology. 2017 Nov 22. doi: 10.1002/hep.29662.
    PubMed     Text format     Abstract available


  453. GIANNINI EG, Bucci L, Garuti F, Brunacci M, et al
    Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice.
    Hepatology. 2017 Nov 21. doi: 10.1002/hep.29668.
    PubMed     Text format     Abstract available


  454. CAST A, Valanejad L, Wright M, Nguyen P, et al
    C/EBPalpha-dependent pre-neoplastic tumor foci are the origin of hepatocellular carcinoma and aggressive pediatric liver cancer.
    Hepatology. 2017 Nov 21. doi: 10.1002/hep.29677.
    PubMed     Text format     Abstract available


  455. HARTMANN P, Hochrath K, Horvath A, Chen P, et al
    Modulation of the intestinal bile acid-FXR-FGF15 axis improves alcoholic liver disease in mice.
    Hepatology. 2017 Nov 21. doi: 10.1002/hep.29676.
    PubMed     Text format     Abstract available


  456. ORNOLFSSON KT, Olafsson S, Bergmann OM, Gershwin ME, et al
    Using the Icelandic Genealogical Database to define the familial risk of primary biliary cholangitis.
    Hepatology. 2017 Nov 21. doi: 10.1002/hep.29675.
    PubMed     Text format     Abstract available


  457. ZHANG XP, Wang K, Chen ZH, Cheng SQ, et al
    Hepatocellular carcinoma with hepatic vein invasion should not be considered as a contraindication for liver resection.
    Hepatology. 2017 Nov 20. doi: 10.1002/hep.29665.
    PubMed     Text format    


  458. HOOKS KB, Audoux J, Fazli H, Lesjean S, et al
    New insights into diagnosis and therapeutic options for proliferative hepatoblastoma.
    Hepatology. 2017 Nov 20. doi: 10.1002/hep.29672.
    PubMed     Text format     Abstract available


  459. PEI Y, Chen XP, Zhang W
    Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: more details, more significance.
    Hepatology. 2017 Nov 20. doi: 10.1002/hep.29666.
    PubMed     Text format    


  460. SIMON TG, King LY, Chong DQ, Nguyen L, et al
    Diabetes, Metabolic Comorbidities and Risk of Hepatocellular Carcinoma: Results from Two Prospective Cohort Studies.
    Hepatology. 2017 Nov 20. doi: 10.1002/hep.29660.
    PubMed     Text format     Abstract available


  461. PARK H, O'Brien TR, Rehermann B
    The role of genetics in hepatic fibrosis amongst HCV patients.
    Hepatology. 2017 Nov 20. doi: 10.1002/hep.29659.
    PubMed     Text format    


  462. LIANG Y, Feng Y, Zong M, Wei X, et al
    beta-Catenin Deficiency in Hepatocytes Aggravates Hepatocarcinogenesis Driven by Oncogenic beta-Catenin and MET.
    Hepatology. 2017 Nov 20. doi: 10.1002/hep.29661.
    PubMed     Text format     Abstract available


  463. CHAUHAN A, Adams DH
    Exercise alters the hepatic immunophenotype to protect against inflammatory liver disease.
    Hepatology. 2017 Nov 16. doi: 10.1002/hep.29657.
    PubMed     Text format    


  464. KAFFE E, Fiorotto R, Pellegrino F, Mariotti V, et al
    beta-catenin and IL-1beta dependent CXCL10 production drives progression of disease in a mouse model of Congenital Hepatic Fibrosis.
    Hepatology. 2017 Nov 15. doi: 10.1002/hep.29652.
    PubMed     Text format     Abstract available


  465. LIU C, Yang Z, Wu J, Zhang L, et al
    lncRNA H19 interacts with polypyrimidine tract-binding protein 1 to reprogram hepatic lipid homeostasis.
    Hepatology. 2017 Nov 15. doi: 10.1002/hep.29654.
    PubMed     Text format     Abstract available


  466. AFONSO MB, Rodrigues CMP
    microRevolution in understanding primary biliary cholangitis pathophysiology.
    Hepatology. 2017 Nov 15. doi: 10.1002/hep.29653.
    PubMed     Text format    


  467. HERMANN A, Wennmann DO, Gromnitza S, Edeling M, et al
    WWC proteins regulate hepatic cell differentiation and tumorigenesis via the Hippo signaling pathway.
    Hepatology. 2017 Nov 8. doi: 10.1002/hep.29647.
    PubMed     Text format     Abstract available


  468. GARCIA-LEZANA T, Raurell I, Bravo M, Torres-Arauz M, et al
    Restoration of A Healthy Intestinal Microbiota Normalizes Portal Hypertension In A Rat Model of Nonalcoholic Steatohepatitis.
    Hepatology. 2017 Nov 7. doi: 10.1002/hep.29646.
    PubMed     Text format     Abstract available


  469. VARSHNEY A, Panda JJ, Singh AK, Yadav N, et al
    Targeted delivery of miR-199a-3p using self-assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma.
    Hepatology. 2017 Nov 6. doi: 10.1002/hep.29643.
    PubMed     Text format     Abstract available


  470. CAUSSY C, Alquiraish MH, Nguyen P, Hernandez C, et al
    Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis.
    Hepatology. 2017 Nov 6. doi: 10.1002/hep.29639.
    PubMed     Text format     Abstract available


  471. FAGGIOLI F, Palagano E, Di Tommaso L, Donadon M, et al
    B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury.
    Hepatology. 2017 Nov 3. doi: 10.1002/hep.29636.
    PubMed     Text format     Abstract available


  472. GUPTA V, Schwartz RE, Shen N, Brown RS Jr, et al
    Hepatology Highlights.
    Hepatology. 2017;66:1367-1369.
    PubMed     Text format    


  473. XIAO G, Zhu S, Xiao X, Yan L, et al
    Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis.
    Hepatology. 2017;66:1486-1501.
    PubMed     Text format     Abstract available


  474. AMATHIEU R, Al-Khafaji A, Sileanu FE, Foldes E, et al
    Significance of oliguria in critically ill patients with chronic liver disease.
    Hepatology. 2017;66:1592-1600.
    PubMed     Text format     Abstract available


  475. FAN Y, Arechederra M, Richelme S, Daian F, et al
    A phosphokinome-based screen uncovers new drug synergies for cancer driven by liver-specific gain of nononcogenic receptor tyrosine kinases.
    Hepatology. 2017;66:1644-1661.
    PubMed     Text format     Abstract available


  476. NAM EJ, Hayashida K, Aquino RS, Couchman JR, et al
    Syndecan-1 limits the progression of liver injury and promotes liver repair in acetaminophen-induced liver injury in mice.
    Hepatology. 2017;66:1601-1615.
    PubMed     Text format     Abstract available


  477. SCHWIMMER JB, Behling C, Angeles JE, Paiz M, et al
    Magnetic resonance elastography measured shear stiffness as a biomarker of fibrosis in pediatric nonalcoholic fatty liver disease.
    Hepatology. 2017;66:1474-1485.
    PubMed     Text format     Abstract available


  478. LU Y, Jiang Z, Dai H, Miao R, et al
    Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway.
    Hepatology. 2017 Nov 1. doi: 10.1002/hep.29633.
    PubMed     Text format     Abstract available


  479. RAEMAN R, Anania FA
    Therapy for steatohepatitis: Do macrophages hold the clue?
    Hepatology. 2017 Nov 1. doi: 10.1002/hep.29630.
    PubMed     Text format    


  480. CAVIGLIA JM, Yan J, Jang MK, Gwak GY, et al
    MicroRNA-21 and Dicer are Dispensable for Hepatic Stellate Cell Activation and the Development of Liver Fibrosis.
    Hepatology. 2017 Nov 1. doi: 10.1002/hep.29627.
    PubMed     Text format     Abstract available


  481. TAPPER EB, Parikh N, Sengupta N, Mellinger J, et al
    A Risk Score to Predict the Development of Hepatic Encephalopathy in a Population-Based Cohort of Patients with Cirrhosis.
    Hepatology. 2017 Nov 1. doi: 10.1002/hep.29628.
    PubMed     Text format     Abstract available


  482. YANG S, Rao J
    Comment on "an endoplasmic reticulum protein, Nogo-B, facilitates alcoholic liver disease through regulation of Kupffer cell polarization".
    Hepatology. 2017;66:1701-1702.
    PubMed     Text format    


  483. XANTHAKOS SA, Trout AT, Dillman JR
    Magnetic resonance elastography assessment of fibrosis in children with NAFLD: Promising but not perfect.
    Hepatology. 2017;66:1373-1376.
    PubMed     Text format    


  484. SCHWEITZER GG, Klein S
    Exercise and NAFLD: Is it worth the effort?
    Hepatology. 2017;66:1691-1694.
    PubMed     Text format    


  485. DOU C, Zheng X, Liu Q, Tu K, et al
    Is the regulatory effect of PCAF and sirtuin 7 on phosphoglycerate kinase 1 acetylation a universal mechanism underlying hepatocellular carcinoma progression?
    Hepatology. 2017;66:1699-1700.
    PubMed     Text format    


  486. KORF H, van der Merwe S
    Adipose-derived exosomal MicroRNAs orchestrate gene regulation in the liver: Is this the missing link in nonalcoholic fatty liver disease?
    Hepatology. 2017;66:1689-1691.
    PubMed     Text format    


  487. CARBONE M, Bonato G, Invernizzi P
    Female preponderance of primary biliary cholangitis is all about our understanding of its autoimmune nature.
    Hepatology. 2017 Nov 1. doi: 10.1002/hep.29625.
    PubMed     Text format    


  488. ELLIS JL, Bove KE, Schuetz EG, Leino D, et al
    Zebrafish abcb11b mutant reveals novel strategies to restore bile excretion impaired by bile salt export pump deficiency.
    Hepatology. 2017 Nov 1. doi: 10.1002/hep.29632.
    PubMed     Text format     Abstract available


    October 2017
  489. AOKI S, Cobbold M, Zhu AX, Duda DG, et al
    Can smart nanomedicine deliver effective targeted cytotoxic treatments to hepatocellular carcinomas while reducing the liver damage?
    Hepatology. 2017 Oct 27. doi: 10.1002/hep.29617.
    PubMed     Text format    


  490. WANG S, Yan ZZ, Yang X, An S, et al
    Hepatocyte DUSP14 maintains metabolic homeostasis and suppresses inflammation in the liver.
    Hepatology. 2017 Oct 27. doi: 10.1002/hep.29616.
    PubMed     Text format     Abstract available


  491. JANSEN PLM
    Hydrodynamics of bile flow Lessons from computational modelling.
    Hepatology. 2017 Oct 27. doi: 10.1002/hep.29618.
    PubMed     Text format    


  492. LIASKOU E, Hirschfield GM
    Genetic association studies and the risk factors for developing the 'immuno-bile-logic' disease PBC.
    Hepatology. 2017 Oct 24. doi: 10.1002/hep.29603.
    PubMed     Text format    


  493. PATEL N, Sheehan-Dare G, Weir J, Verma S, et al
    Cutaneous metastasis as the first presentation of hepatocellular carcinoma.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29615.
    PubMed     Text format    


  494. SHEN Q, Eun JW, Lee K, Kim HS, et al
    BANF1, PLOD3, SF3B4 as Early-stage Cancer Decision Markers and Drivers of Hepatocellular Carcinoma.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29606.
    PubMed     Text format     Abstract available


  495. PRAKTIKNJO M, Book M, Luetkens J, Pohlmann A, et al
    Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29602.
    PubMed     Text format     Abstract available


  496. SHEN F, Li Y, Yang Wang, Sozzi V, et al
    Hepatitis B Virus Sensitivity to Interferon-alpha in Hepatocytes is More Associated with Cellular Interferon Response than with Viral Genotype.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29609.
    PubMed     Text format     Abstract available


  497. KO E, Seo HW, Jung G
    Telomere length and ROS levels are positively associated with a high risk of mortality and recurrence in hepatocellular carcinoma.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29604.
    PubMed     Text format     Abstract available


  498. JANSEN C, Moller P, Meyer C, Kolbe CC, et al
    Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortality.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29612.
    PubMed     Text format     Abstract available


  499. PHILIPS CA, Kumar L, Augustine P
    Partial Splenic Artery Embolization for Severe Hepatic Myelopathy in Cirrhosis.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29597.
    PubMed     Text format     Abstract available


  500. SHERMAN M
    Regorafenib for treatment of hepatocellular carcinoma.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29598.
    PubMed     Text format    


  501. MIDDLETON MS, Van Natta ML, Heba ER, Alazraki A, et al
    Diagnostic Accuracy of Magnetic Resonance Imaging Hepatic Proton Density Fat Fraction in Pediatric Nonalcoholic Fatty Liver Disease.
    Hepatology. 2017 Oct 13. doi: 10.1002/hep.29596.
    PubMed     Text format     Abstract available


  502. VON LOEFFELHOLZ C, Birkenfeld AL
    Is mIndy a mediator of energy metabolism reprogramming in hepatocellular carcinoma induced by IL-6/STAT3 signaling?
    Hepatology. 2017 Oct 12. doi: 10.1002/hep.29591.
    PubMed     Text format    


  503. LU L, Yue S, Jiang L, Li C, et al
    Myeloid Notch1 Deficiency Activates RhoA/ROCK Pathway and Aggravates Hepatocellular Damage In Mouse Ischemic Livers.
    Hepatology. 2017 Oct 12. doi: 10.1002/hep.29593.
    PubMed     Text format     Abstract available


  504. TOSKICH B, Patel T
    Radioembolization for hepatocellular carcinoma - the time has come.
    Hepatology. 2017 Oct 12. doi: 10.1002/hep.29590.
    PubMed     Text format    


  505. CHEN Y, Zeng Z, Lu Y
    Is mIndy a mediator of energy metabolism reprogramming in hepatocellular carcinoma induced by IL-6/STAT3 signaling?
    Hepatology. 2017 Oct 12. doi: 10.1002/hep.29592.
    PubMed     Text format    


  506. YANG JD, Mannalithara A, Piscitello AJ, Kisiel JB, et al
    Impact of Surveillance for Hepatocellular Carcinoma on Survival in Patients with Compensated Cirrhosis.
    Hepatology. 2017 Oct 12. doi: 10.1002/hep.29594.
    PubMed     Text format     Abstract available


  507. EHRLICH L, Glaser SS
    Novel beta-catenin/FXR Interaction Regulates Hepatic Bile Acid Metabolism During Cholestasis.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29584.
    PubMed     Text format    


  508. RAMMOHAN A, Reddy MS, Farouk M, Vargese J, et al
    Pembrolizumab for Metastatic Hepatocellular Carcinoma Following Live Donor Liver Transplantation: The Silver Bullet?
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29575.
    PubMed     Text format     Abstract available


  509. SIDHU SS, Sharma BC, Goyal O, Kishore H, et al
    Reply: Terminating an episode of overt hepatic encephalopathy - L - ornithine L-aspartate may have some role.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29571.
    PubMed     Text format    


  510. WANG F, Hongwei T, Li L, Piontek K, et al
    Exosome - miR-335 as a novel therapeutic strategy in hepatocellular carcinoma.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29586.
    PubMed     Text format     Abstract available


  511. ZHAO J, Adams A, Roberts B, O'Neil M, et al
    PRMT1 and JMJD6 dependent arginine methylation regulate HNF4alpha expression and hepatocyte proliferation.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29587.
    PubMed     Text format     Abstract available


  512. RATHI S, Taneja S
    Terminating an episode of overt hepatic encephalopathy- Lornithine L-aspartate may have some role.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29570.
    PubMed     Text format    


  513. MONTANO-LOZA AJ, Mazurak VC, Ebadi M, Meza-Junco J, et al
    Visceral adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29578.
    PubMed     Text format     Abstract available


  514. MURPHY AG, Selaru F
    Extracellular vesicles as novel therapeutics in hepatic failure.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29576.
    PubMed     Text format    


  515. MACDONALD S, Andreola F, Bachtiger P, Amoros A, et al
    Cell death markers in cirrhotic patients with acute decompensation.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29581.
    PubMed     Text format     Abstract available


  516. MASYUK AI, Masyuk TV, Lorenzo Pisarello MJ, Ding JF, et al
    Cholangiocyte Autophagy Contributes to Hepatic Cystogenesis in Polycystic Liver Disease and Represents a Potential Therapeutic Target.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29577.
    PubMed     Text format     Abstract available


  517. PRADHAN-SUNDD T, Zhou L, Vats R, Jiang A, et al
    Dual catenin loss in murine liver causes tight junctional deregulation and progressive intrahepatic cholestasis.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29585.
    PubMed     Text format     Abstract available


  518. BARBIER L, Ronot M, Aussilhou B, Cauchy F, et al
    Polycystic liver disease: Hepatic venous outflow obstruction lesions of the non-cystic parenchyma have major consequences.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29582.
    PubMed     Text format     Abstract available


  519. RAEVENS S, Geerts A, Paridaens A, Lefere S, et al
    Placental growth factor inhibition targets pulmonary angiogenesis and represents a novel therapy for hepatopulmonary syndrome in mice.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29579.
    PubMed     Text format     Abstract available


  520. KOWDLEY KV, Luketic V, Chapman R, Hirschfield GM, et al
    A Randomized Trial of Obeticholic Acid Monotherapy in Patients with Primary Biliary Cholangitis.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29569.
    PubMed     Text format     Abstract available


  521. RUSSO N, Brown RS Jr, Schwartz RE, Rosenblatt R, et al
    Hepatology Highlights.
    Hepatology. 2017;66:1013-1015.
    PubMed     Text format    


  522. ALBILLOS A, Zamora J, Martinez J, Arroyo D, et al
    Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis.
    Hepatology. 2017;66:1219-1231.
    PubMed     Text format     Abstract available


  523. SO-ARMAH KA, Lim JK, Lo Re V, Tate JP, et al
    FIB-4 stage of liver fibrosis predicts incident heart failure among HIV-infected and uninfected patients.
    Hepatology. 2017;66:1286-1295.
    PubMed     Text format     Abstract available


  524. KOLACHALA VL, Palle S, Shen M, Feng A, et al
    Loss of L-selectin-guided CD8+ , but not CD4+ , cells protects against ischemia reperfusion injury in a steatotic liver.
    Hepatology. 2017;66:1258-1274.
    PubMed     Text format     Abstract available


  525. BASURAY S, Smagris E, Cohen JC, Hobbs HH, et al
    The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation.
    Hepatology. 2017;66:1111-1124.
    PubMed     Text format     Abstract available


  526. BANGEN JM, Hammerich L, Sonntag R, Baues M, et al
    Targeting CCl4 -induced liver fibrosis by RNA interference-mediated inhibition of cyclin E1 in mice.
    Hepatology. 2017;66:1242-1257.
    PubMed     Text format     Abstract available


  527. LIU Z, Que S, Mardinoglu A
    Rediscussion on linearity between fibrosis stages and mortality risk in nonalcoholic fatty liver disease patients.
    Hepatology. 2017;66:1357-1358.
    PubMed     Text format    


  528. SAFIRI S, Khazaei S, Mansori K, Ayubi E, et al
    Comments on "Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis".
    Hepatology. 2017;66:1358-1359.
    PubMed     Text format    


  529. VALENTI L, Dongiovanni P
    Mutant PNPLA3 I148M protein as pharmacological target for liver disease.
    Hepatology. 2017;66:1026-1028.
    PubMed     Text format    


    September 2017
  530. KAKAR S, Ferrell LD
    Glutamine synthetase staining and CTTNB1 mutation in hepatocellular adenomas.
    Hepatology. 2017 Sep 29. doi: 10.1002/hep.29567.
    PubMed     Text format    


  531. RIORDAN JD, Feddersen CR, Tschida BR, Jackson P, et al
    Chronic liver injury alters driver mutation profiles in hepatocellular carcinoma.
    Hepatology. 2017 Sep 29. doi: 10.1002/hep.29565.
    PubMed     Text format     Abstract available


  532. REBOUISSOU S, Bioulac-Sage P, Nault JC, Calderaro J, et al
    Reply to << Glutamine synthetase staining and CTNNB1 mutation in hepatocellular adenomas >>.
    Hepatology. 2017 Sep 29. doi: 10.1002/hep.29563.
    PubMed     Text format    


  533. OU-YANG Q, Lin XM, Zhu YJ, Zheng B, et al
    Distinct Role of Nuclear Receptor Corepressor 1 Regulated de novo Fatty Acids Synthesis in Liver Regeneration and Hepatocarcinogenesis.
    Hepatology. 2017 Sep 28. doi: 10.1002/hep.29562.
    PubMed     Text format     Abstract available


  534. TIMCHENKO NA
    Mitochondrial and anabolic pathways in hepatocellular carcinoma.
    Hepatology. 2017 Sep 28. doi: 10.1002/hep.29559.
    PubMed     Text format    


  535. LUO P, Yin P, Hua R, Tan Y, et al
    A large-scale, multi-center serum metabolite biomarkers identification study for the early detection of hepatocellular carcinoma.
    Hepatology. 2017 Sep 28. doi: 10.1002/hep.29561.
    PubMed     Text format     Abstract available


  536. CHTIOUI H
    OATP1B1 and DAA treatment for hepatitis C in patients with hepatocellular carcinoma.
    Hepatology. 2017 Sep 27. doi: 10.1002/hep.29556.
    PubMed     Text format    


  537. SORIA A, Lapadula G, Fabbiani M, Gori A, et al
    Treatment failure with DAA in hepatocellular carcinoma: More than one explanation?
    Hepatology. 2017 Sep 27. doi: 10.1002/hep.29553.
    PubMed     Text format    


  538. KRENKEL O, Puengel T, Govaere O, Abdallah AT, et al
    Therapeutic Inhibition of Inflammatory Monocyte Recruitment Reduces Steatohepatitis and Liver Fibrosis.
    Hepatology. 2017 Sep 21. doi: 10.1002/hep.29544.
    PubMed     Text format     Abstract available


  539. WYLES D, Poordad F, Wang S, Alric L, et al
    Glecaprevir/Pibrentasvir for HCV Genotype 3 Patients with Cirrhosis and/or Prior Treatment Experience: A Partially Randomized Phase III Clinical Trial.
    Hepatology. 2017 Sep 19. doi: 10.1002/hep.29541.
    PubMed     Text format     Abstract available


  540. LIU R, Li X, Huang Z, Zhao D, et al
    CHOP-induced loss of intestinal epithelial stemness contributes to bile duct ligation-induced cholestatic liver injury.
    Hepatology. 2017 Sep 19. doi: 10.1002/hep.29540.
    PubMed     Text format     Abstract available


  541. ERICE O, Munoz-Garrido P, Vaquero J, Perugorria MJ, et al
    MiRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation.
    Hepatology. 2017 Sep 18. doi: 10.1002/hep.29533.
    PubMed     Text format     Abstract available


  542. LEE MH, Huang YH, Chen HY, Khor CS, et al
    Human Leukocyte Antigen Variants and Risk of Hepatocellular Carcinoma Modified by HCV Genotypes: A Genome-wide Association Study.
    Hepatology. 2017 Sep 16. doi: 10.1002/hep.29531.
    PubMed     Text format     Abstract available


  543. LO RE O, Fusilli C, Rappa F, Van Haele M, et al
    Induction of cancer cell stemness by depletion of macrohistone H2A1 in hepatocellular carcinoma.
    Hepatology. 2017 Sep 15. doi: 10.1002/hep.29519.
    PubMed     Text format     Abstract available


  544. CESARI M, Frigo AC, Tonon M, Angeli P, et al
    Cardiovascular predictors of death in patients with cirrhosis.
    Hepatology. 2017 Sep 13. doi: 10.1002/hep.29520.
    PubMed     Text format     Abstract available


  545. WINTERS AC, Tremblay D, Arinsburg S, Mascarenhas J, et al
    Reassessing the Safety Concerns of Utilizing Blood Donations from Patients with Hemochromatosis.
    Hepatology. 2017 Sep 13. doi: 10.1002/hep.29521.
    PubMed     Text format     Abstract available


  546. PISCAGLIA F, Tovoli F, Pini P, Salvatore V, et al
    A new horizon in the prevention of the postembolization syndrome after Transcatheter Arterial Chemioembolization for hepatocellular carcinoma.
    Hepatology. 2017 Sep 13. doi: 10.1002/hep.29517.
    PubMed     Text format    


  547. RIMOLA J, Diaz-Gonzalez A, Darnell A, Varela M, et al
    Complete response under sorafenib in patients with hepatocellular carcinoma. Relationship with dermatologic adverse events.
    Hepatology. 2017 Sep 12. doi: 10.1002/hep.29515.
    PubMed     Text format     Abstract available


  548. WANG B, Fu J, Yu T, Xu A, et al
    Contradictory Effects of Mitochondria- and Non-mitochondria-targeted Antioxidants on Hepatocarcinogenesis by Altering DNA Repair.
    Hepatology. 2017 Sep 12. doi: 10.1002/hep.29518.
    PubMed     Text format     Abstract available


  549. LOOMBA R, Lawitz E, Mantry PS, Jayakumar S, et al
    The ASK1 Inhibitor Selonsertib in Patients with Nonalcoholic Steatohepatitis: A Randomized, Phase 2 Trial.
    Hepatology. 2017 Sep 11. doi: 10.1002/hep.29514.
    PubMed     Text format     Abstract available


  550. LIU CH, Chern GG, Hsu FF, Huang KW, et al
    A multifunctional nanocarrier for efficient TRAIL-based gene therapy against hepatocellular carcinoma with desmoplasia.
    Hepatology. 2017 Sep 8. doi: 10.1002/hep.29513.
    PubMed     Text format     Abstract available


  551. FINN RS, Zhu AX, Wigdan F, Almasri J, et al
    Therapies for Advanced Stage Hepatocellular Carcinoma with Macrovascular invasion or Metastatic Disease: a Systematic Review and Meta-analysis.
    Hepatology. 2017 Sep 7. doi: 10.1002/hep.29486.
    PubMed     Text format     Abstract available


  552. MARSHALL K, Jin J, Atkinson C, Alawieh A, et al
    Natural IgM initiates an inflammatory response important for both hepatic ischemia reperfusion injury and regeneration.
    Hepatology. 2017 Sep 7. doi: 10.1002/hep.29512.
    PubMed     Text format     Abstract available


  553. BORENTAIN P, Colson P, Bolon E, Gauchez P, et al
    Hepatocellular carcinoma complicating hepatitis E virus-related cirrhosis.
    Hepatology. 2017 Sep 5. doi: 10.1002/hep.29508.
    PubMed     Text format    



  554. ERRATUM for Beta-blockers in 2016: Still the safest and most useful drugs for portal hypertension?
    Hepatology. 2017 Sep 4. doi: 10.1002/hep.29171.
    PubMed     Text format    


  555. SCHWARTZ RE, Batisti J, Brown RS Jr, Tafesh Z, et al
    Hepatology Highlights.
    Hepatology. 2017;66:683-685.
    PubMed     Text format    


  556. BOUATTOUR M, Raymond E, Qin S, Cheng AL, et al
    Recent Developments of c-Met as a Therapeutic Target in Hepatocellular Carcinoma.
    Hepatology. 2017 Sep 1. doi: 10.1002/hep.29496.
    PubMed     Text format     Abstract available


  557. TAKYAR V, Nath A, Beri A, Gharib AM, et al
    How healthy are the "Healthy volunteers"? Penetrance of NAFLD in the biomedical research volunteer pool.
    Hepatology. 2017;66:825-833.
    PubMed     Text format     Abstract available


  558. KACHAYLO E, Tschuor C, Calo N, Borgeaud N, et al
    PTEN Down-Regulation Promotes beta-Oxidation to Fuel Hypertrophic Liver Growth After Hepatectomy in Mice.
    Hepatology. 2017;66:908-921.
    PubMed     Text format     Abstract available


  559. PEREA L, Coll M, Sanjurjo L, Blaya D, et al
    Pentraxin-3 modulates lipopolysaccharide-induced inflammatory response and attenuates liver injury.
    Hepatology. 2017;66:953-968.
    PubMed     Text format     Abstract available


  560. SANGRO B, Martinez-Urbistondo D, Bester L, Bilbao JI, et al
    Prevention and treatment of complications of selective internal radiation therapy: Expert guidance and systematic review.
    Hepatology. 2017;66:969-982.
    PubMed     Text format     Abstract available


  561. PANDEY S
    Healthy controls in nonalcoholic fatty liver disease management: A biomedical research perspective.
    Hepatology. 2017;66:1006-1007.
    PubMed     Text format    


  562. LO GH
    Do we need vasoconstrictors up to 5 days after successful hemostasis by ligation of bleeding varices?
    Hepatology. 2017;66:1009.
    PubMed     Text format    


  563. DELLAVANCE A, Ferraz MLG, Cancado ELR, Andrade LEC, et al
    Expansion and intensification of humoral autoimmune response in the transition from preclinical to full-blown primary biliary cholangitis.
    Hepatology. 2017;66:997.
    PubMed     Text format    


    August 2017
  564. ROBERTS LR, Sirlin CB, Zaiem F, Almasri J, et al
    Imaging for the Diagnosis of Hepatocellular Carcinoma: a Systematic Review and Meta-analysis.
    Hepatology. 2017 Aug 31. doi: 10.1002/hep.29487.
    PubMed     Text format     Abstract available


  565. KULIK L, Heimbach JK, Zaiem F, Almasri J, et al
    Therapies for Patients with Hepatocellular Carcinoma Awaiting for Liver Transplantation: a Systematic Review and Meta-analysis.
    Hepatology. 2017 Aug 31. doi: 10.1002/hep.29485.
    PubMed     Text format     Abstract available


  566. PICCININ E, Peres C, Bellafante E, Ducheix S, et al
    Hepatic PPARgamma coactivator 1beta drives mitochondrial and anabolic signatures that contribute to hepatocellular carcinoma progression.
    Hepatology. 2017 Aug 31. doi: 10.1002/hep.29484.
    PubMed     Text format     Abstract available


  567. VYAS D, Baptista PM, Brovold M, Moran E, et al
    Self-assembled liver organoids recapitulate hepato-biliary organogenesis in vitro.
    Hepatology. 2017 Aug 23. doi: 10.1002/hep.29483.
    PubMed     Text format     Abstract available


  568. YANG JD, Malhi H
    Green Tea Consumption - A Potential Chemopreventive Measure for Hepatocellular Carcinoma?
    Hepatology. 2017 Aug 21. doi: 10.1002/hep.29481.
    PubMed     Text format    


  569. KABIR TD, Ganda C, Brown RM, Beveridge DJ, et al
    A miR-7/GAS6/TYRO3 axis regulates the growth and invasiveness of sorafenib-resistant cells in human hepatocellular carcinoma.
    Hepatology. 2017 Aug 18. doi: 10.1002/hep.29478.
    PubMed     Text format     Abstract available


  570. RIAZ A, Gabr A, Abouchaleh N, Ali R, et al
    Radioembolization for Hepatocellular Carcinoma: Statistical Confirmation of Improved Survival in Responders by Landmark Analyses.
    Hepatology. 2017 Aug 18. doi: 10.1002/hep.29480.
    PubMed     Text format     Abstract available


  571. WARD ES, Ober RJ
    Hepatic function of FcRn revealed: Implications for overcoming drug-mediated hepatotoxicity.
    Hepatology. 2017 Aug 17. doi: 10.1002/hep.29476.
    PubMed     Text format    


  572. FRIEDMAN SL, Ratziu V, Harrison SA, Abdelmalek MF, et al
    A Randomized, Placebo-Controlled Trial of Cenicriviroc for Treatment of Nonalcoholic Steatohepatitis with Fibrosis.
    Hepatology. 2017 Aug 17. doi: 10.1002/hep.29477.
    PubMed     Text format     Abstract available


  573. PARIKH ND, Marrero WJ, Wang J, Steuer J, et al
    Projected increase in obesity and non-alcoholic steatohepatitis-related liver transplantation waitlist additions in the United States.
    Hepatology. 2017 Aug 17. doi: 10.1002/hep.29473.
    PubMed     Text format     Abstract available


  574. DEMAREZ C, Gerard C, Cordi S, Poncy A, et al
    MiR-337-3p controls hepatobiliary gene expression and transcriptional dynamics during hepatic cell differentiation.
    Hepatology. 2017 Aug 17. doi: 10.1002/hep.29475.
    PubMed     Text format     Abstract available


  575. DE HAAS RJ, Lim C, Bhangui P, Salloum C, et al
    Curative Salvage Liver Transplantation in Cirrhotic patients with Hepatocellular Carcinoma: An intention-to-treat analysis.
    Hepatology. 2017 Aug 14. doi: 10.1002/hep.29468.
    PubMed     Text format     Abstract available


  576. HALGAND B, Desterke C, Riviere L, Fallot G, et al
    Hepatitis B virus pregenomic RNA in hepatocellular carcinoma: A nosological and prognostic determinant.
    Hepatology. 2017 Aug 12. doi: 10.1002/hep.29463.
    PubMed     Text format     Abstract available


  577. LIN YH, Wu MH, Huang YH, Yeh CT, et al
    Taurine upregulated gene 1 functions as a master regulator to coordinate glycolysis and metastasis in hepatocellular carcinoma.
    Hepatology. 2017 Aug 12. doi: 10.1002/hep.29462.
    PubMed     Text format     Abstract available


  578. MATSUDA M, Tsurusaki S, Miyata N, Saijou E, et al
    Oncostatin M causes liver fibrosis by regulating cooperation between hepatic stellate cells and macrophages in mice.
    Hepatology. 2017 Aug 5. doi: 10.1002/hep.29421.
    PubMed     Text format     Abstract available


  579. KRISS M, Burchill M
    HCV and non-hepatic malignancy: Is pre-emptive DAA therapy indicated prior to treatment?
    Hepatology. 2017 Aug 2. doi: 10.1002/hep.29414.
    PubMed     Text format    


  580. SCHNEIDER Y, Brown RS, Saumoy M, Schwartz RE, et al
    Hepatology Highlights - August 2017.
    Hepatology. 2017;66:309-311.
    PubMed     Text format    


  581. STIEDE K, Miao W, Blanchette HS, Beysen C, et al
    Acetyl-coenzyme A carboxylase inhibition reduces de novo lipogenesis in overweight male subjects: A randomized, double-blind, crossover study.
    Hepatology. 2017;66:324-334.
    PubMed     Text format     Abstract available


  582. KOH C, Sakiani S, Surana P, Zhao X, et al
    Adult-onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entity.
    Hepatology. 2017;66:591-601.
    PubMed     Text format     Abstract available


  583. LAI JC, Covinsky KE, Dodge JL, Boscardin WJ, et al
    Development of a novel frailty index to predict mortality in patients with end-stage liver disease.
    Hepatology. 2017;66:564-574.
    PubMed     Text format     Abstract available


  584. LIU S, Sun Y, Jiang M, Li Y, et al
    Glyceraldehyde-3-phosphate dehydrogenase promotes liver tumorigenesis by modulating phosphoglycerate dehydrogenase.
    Hepatology. 2017;66:631-645.
    PubMed     Text format     Abstract available


  585. HUNT CM, Papay JI, Stanulovic V, Regev A, et al
    Drug rechallenge following drug-induced liver injury.
    Hepatology. 2017;66:646-654.
    PubMed     Text format     Abstract available


  586. SAIKIA P, Bellos D, McMullen MR, Pollard KA, et al
    MicroRNA 181b-3p and its target importin alpha5 regulate toll-like receptor 4 signaling in Kupffer cells and liver injury in mice in response to ethanol.
    Hepatology. 2017;66:602-615.
    PubMed     Text format     Abstract available


  587. SANOFF HK, Chang Y, Lund JL, O'Neil BH, et al
    Immortal time bias or sorafenib effect in elderly patients with HCC?
    Hepatology. 2017;66:678-679.
    PubMed     Text format    


  588. PONZETTO A, Perez-Perez GI, Figura N
    Alpha1-antitrypsin deficiency and c-JUN.
    Hepatology. 2017;66:677.
    PubMed     Text format    


  589. HE Y, Gao B
    A small specific-sized hyaluronic acid ameliorates alcoholic liver disease by targeting a small RNA: New hope for therapy?
    Hepatology. 2017;66:321-323.
    PubMed     Text format    


  590. FAN H, Zhu JH
    FABP1 as a novel potential biomarker for predicting mortality in acetaminophen-induced acute liver failure.
    Hepatology. 2017;66:670.
    PubMed     Text format    


  591. GEIER A, Jahn D, Hermanns HM
    Interleukin-6: The dark side of liver regeneration in chronic liver disease.
    Hepatology. 2017;66:667-668.
    PubMed     Text format    


  592. ICHIKAWA S, Motosugi U, Oguri M, Onishi H, et al
    Magnetic resonance elastography for prediction of radiation-induced liver disease after stereotactic body radiation therapy.
    Hepatology. 2017;66:664-665.
    PubMed     Text format    


  593. AZOULAY D, Lahat E, Salloum C, Compagnon P, et al
    Heterotopic liver retransplantation for impossible former graft explantation.
    Hepatology. 2017;66:655-657.
    PubMed     Text format    


    July 2017
  594. GU J, Jeong S, Xia Q
    Intrahepatic cholangiocarcinoma arising from HBV Infection may be a highly selected population for liver transplantation.
    Hepatology. 2017 Jul 31. doi: 10.1002/hep.29413.
    PubMed     Text format    


  595. SIDHU SS, Sharma BC, Goyal O, Kishore H, et al
    L-ornithine L-aspartate in bouts of overt hepatic encephalopathy.
    Hepatology. 2017 Jul 27. doi: 10.1002/hep.29410.
    PubMed     Text format     Abstract available


  596. COBB DA, Golden-Mason L, Rosen HR, Hahn YS, et al
    Hepatocyte-derived exosomes promote T follicular regulatory cell expansion during HCV infection.
    Hepatology. 2017 Jul 27. doi: 10.1002/hep.29409.
    PubMed     Text format     Abstract available


  597. TANDON P, Madsen K, Kao D
    Fecal microbiota transplantation for hepatic encephalopathy - ready for prime time?
    Hepatology. 2017 Jul 22. doi: 10.1002/hep.29396.
    PubMed     Text format    


  598. SAUERBRUCH T
    Continuation of non-selective beta-blockers for patients with liver cirrhosis and hemodynamic non-response?
    Hepatology. 2017 Jul 22. doi: 10.1002/hep.29394.
    PubMed     Text format    


  599. ZHU L, Baker RD, Zhu R, Baker SS, et al
    Sequencing the gut metagenome as a non-invasive diagnosis for advanced nonalcoholic steatohepatitis.
    Hepatology. 2017 Jul 21. doi: 10.1002/hep.29387.
    PubMed     Text format    


  600. LI H, Li X, Liu S, Guo L, et al
    PD-1 Checkpoint Blockade in Combination with an mTOR Inhibitor Restrains Hepatocellular Carcinoma Growth Induced by Hepatoma Cell-Intrinsic PD-1.
    Hepatology. 2017 Jul 21. doi: 10.1002/hep.29360.
    PubMed     Text format     Abstract available


  601. PEDERSEN JS, Kimer N, Henriksen JH, Bendtsen F, et al
    The Royal Free Hospital Cirrhosis Glomerular Filtration Rate: Validation in a Danish Cohort.
    Hepatology. 2017 Jul 20. doi: 10.1002/hep.29386.
    PubMed     Text format    


  602. HIJMANS BS, Boss A, van Dijk TH, Soty M, et al
    Hepatocytes contribute to residual glucose production in a mouse model for glycogen storage disease type Ia.
    Hepatology. 2017 Jul 20. doi: 10.1002/hep.29389.
    PubMed     Text format     Abstract available


  603. KALAFATELI M, Tsochatzis EA
    Reply to "The Royal Free Hospital Cirrhosis Glomerular Filtration Rate: Validation in a Danish Cohort."
    Hepatology. 2017 Jul 20. doi: 10.1002/hep.29391.
    PubMed     Text format    


  604. FU Y, Silverstein S, McCutcheon JN, Dyba M, et al
    An endogenous DNA adduct as a prognostic biomarker for hepatocarcinogenesis and its prevention by Theaphenon E in mice.
    Hepatology. 2017 Jul 18. doi: 10.1002/hep.29380.
    PubMed     Text format     Abstract available


  605. AN S, Zhao LP, Shen LJ, Wang S, et al
    USP18 protects against hepatic steatosis and insulin resistance via its DUB activity.
    Hepatology. 2017 Jul 17. doi: 10.1002/hep.29375.
    PubMed     Text format     Abstract available


  606. MULLISH BH, McDonald JAK, Thursz MR, Marchesi JR, et al
    Correspondence: Fecal Microbiota Transplant from a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial.
    Hepatology. 2017 Jul 17. doi: 10.1002/hep.29369.
    PubMed     Text format    


  607. ARDEVOL A, Ibanez-Sanz G, Profitos J, Aracil C, et al
    Survival of patients with cirrhosis and acute peptic ulcer bleeding compared with variceal bleeding using current first-line therapies.
    Hepatology. 2017 Jul 17. doi: 10.1002/hep.29370.
    PubMed     Text format     Abstract available


  608. WU H, Tao J, Li X, Zhang T, et al
    MicroRNA-206 Prevents the Pathogenesis of Hepatocellular Carcinoma Via Modulating Expression of cMet and Cdk6.
    Hepatology. 2017 Jul 17. doi: 10.1002/hep.29374.
    PubMed     Text format     Abstract available


  609. PURI P, Daita K, Joyce A, Mirshahi F, et al
    The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids.
    Hepatology. 2017 Jul 11. doi: 10.1002/hep.29359.
    PubMed     Text format     Abstract available


  610. SARWAR A, Zhou L, Novack V, Tapper EB, et al
    Hospital volume and mortality after trans-jugular intrahepatic portosystemic shunt creation in the United States.
    Hepatology. 2017 Jul 6. doi: 10.1002/hep.29354.
    PubMed     Text format     Abstract available


  611. YANG L, Wang WH, Qiu WL, Guo Z, et al
    A single-cell transcriptomic analysis reveals precise pathways and regulatory mechanisms underlying hepatoblast differentiation.
    Hepatology. 2017 Jul 6. doi: 10.1002/hep.29353.
    PubMed     Text format     Abstract available



  612. Hepatology Highlights.
    Hepatology. 2017;66:1-3.
    PubMed     Text format    


  613. CASSANO M, Offner S, Planet E, Piersigilli A, et al
    Polyphenic trait promotes liver cancer in a model of epigenetic instability in mice.
    Hepatology. 2017;66:235-251.
    PubMed     Text format     Abstract available


  614. PICCOLO P, Annunziata P, Soria LR, Attanasio S, et al
    Down-regulation of hepatocyte nuclear factor-4alpha and defective zonation in livers expressing mutant Z alpha1-antitrypsin.
    Hepatology. 2017;66:124-135.
    PubMed     Text format     Abstract available


  615. UNALP-ARIDA A, Ruhl CE
    Liver fibrosis scores predict liver disease mortality in the United States population.
    Hepatology. 2017;66:84-95.
    PubMed     Text format     Abstract available


  616. MUELLER S, Nahon P, Rausch V, Peccerella T, et al
    Caspase-cleaved keratin-18 fragments increase during alcohol withdrawal and predict liver-related death in patients with alcoholic liver disease.
    Hepatology. 2017;66:96-107.
    PubMed     Text format     Abstract available


  617. YI S, Sahni N
    Regulome networks and mutational landscape in liver cancer: An informative path to precision medicine.
    Hepatology. 2017;66:280-282.
    PubMed     Text format    


  618. YIP TC, Wong VW
    How to identify patients with advanced liver disease in the community?
    Hepatology. 2017;66:7-9.
    PubMed     Text format    


  619. CARDOSO FS, Pereira R, Alexandrino G, Bagulho L, et al
    Futility of care in patients with acute-on-chronic liver failure.
    Hepatology. 2017;66:292-294.
    PubMed     Text format    


    June 2017
  620. CHENG X, Xia Y, Serti E, Block PD, et al
    Hepatitis B virus evades innate immunity of hepatocytes but activates macrophages during infection.
    Hepatology. 2017 Jun 30. doi: 10.1002/hep.29348.
    PubMed     Text format     Abstract available


  621. LIU J, Hu X, Chen J, Li X, et al
    Pericentral hepatocytes produce IGF-2 to promote liver regeneration during special injuries.
    Hepatology. 2017 Jun 27. doi: 10.1002/hep.29340.
    PubMed     Text format     Abstract available


  622. LAI Q, Vitale A, Iesari S, Finkenstedt A, et al
    Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer.
    Hepatology. 2017 Jun 27. doi: 10.1002/hep.29342.
    PubMed     Text format     Abstract available


  623. HENRIET E, Hammoud AA, Dupuy JW, Dartigues B, et al
    Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding risk.
    Hepatology. 2017 Jun 23. doi: 10.1002/hep.29336.
    PubMed     Text format     Abstract available


  624. TSAI CL, Liu WL, Hsu FM, Yang PS, et al
    Targeting Histone deacetylase 4/Ubc9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells.
    Hepatology. 2017 Jun 23. doi: 10.1002/hep.29328.
    PubMed     Text format     Abstract available


  625. LIU Y, Zhang Y, Wang S, Dong QZ, et al
    Prospero-related homeobox 1 drives angiogenesis of hepatocellular carcinoma through selectively activating IL-8 expression.
    Hepatology. 2017 Jun 23. doi: 10.1002/hep.29337.
    PubMed     Text format     Abstract available


  626. DAWSON PA
    Hepatic bile acid uptake in humans and mice: Multiple pathways and expanding potential role for gut-liver signaling.
    Hepatology. 2017 Jun 23. doi: 10.1002/hep.29325.
    PubMed     Text format    


  627. ZHANG C, Huang J, An W
    Hepatic stimulator substance resists hepatic ischemia-reperfusion injury by regulating Drp1 translocation and activation.
    Hepatology. 2017 Jun 23. doi: 10.1002/hep.29326.
    PubMed     Text format     Abstract available


  628. YIP LY, Aw CC, Lee SH, Hong YS, et al
    The Liver-Gut Microbiota Axis Modulates Hepatotoxicity of Tacrine in the Rat.
    Hepatology. 2017 Jun 23. doi: 10.1002/hep.29327.
    PubMed     Text format     Abstract available


  629. KIM DS, Ryu JW, Son MY, Oh JH, et al
    A Liver-specific Gene Expression Panel Predicts the Differentiation Status of in vitro Hepatocyte Models.
    Hepatology. 2017 Jun 22. doi: 10.1002/hep.29324.
    PubMed     Text format     Abstract available


  630. PAPATHEODORIDIS GV, Idilman R, Dalekos GN, Buti M, et al
    The risk of hepatocellular carcinoma is decreasing after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B.
    Hepatology. 2017 Jun 16. doi: 10.1002/hep.29320.
    PubMed     Text format     Abstract available


  631. CHIDA T, Ito M, Nakashima K, Kanegae Y, et al
    Critical role of CREBH-mediated induction of TGF-beta2 by HCV infection in fibrogenic responses in hepatic stellate cells.
    Hepatology. 2017 Jun 16. doi: 10.1002/hep.29319.
    PubMed     Text format     Abstract available


  632. LEE M, Chung GE, Lee JH, Oh S, et al
    Antiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment.
    Hepatology. 2017 Jun 15. doi: 10.1002/hep.29318.
    PubMed     Text format     Abstract available


  633. GAO Y, Feng J, Yang G, Zhang S, et al
    HBx-elevated MSL2 Modulates HBV cccDNA through Inducing Degradation of APOBEC3B to Enhance Hepatocarcinogenesis.
    Hepatology. 2017 Jun 13. doi: 10.1002/hep.29316.
    PubMed     Text format     Abstract available


  634. TAYLOR EJ, Jones RL, Guthrie JA, Rowe IA, et al
    Modelling the benefits and harms of surveillance for hepatocellular carcinoma: information to support informed choices.
    Hepatology. 2017 Jun 12. doi: 10.1002/hep.29315.
    PubMed     Text format     Abstract available


  635. JIANG L, Yan Q, Fang S, Liu M, et al
    Calcium binding protein 39 promotes hepatocellular carcinoma growth and metastasis by activating ERK signaling pathway.
    Hepatology. 2017 Jun 12. doi: 10.1002/hep.29312.
    PubMed     Text format     Abstract available


  636. BALWANI M, Wang B, Anderson KE, Bloomer JR, et al
    Acute Hepatic Porphyrias: Recommendations for Evaluation and Long Term Management.
    Hepatology. 2017 Jun 12. doi: 10.1002/hep.29313.
    PubMed     Text format     Abstract available


  637. ZHENG C, Zeng H, Lin H, Wang J, et al
    Serum microcystins level positively linked with risk of hepatocellular carcinoma: a case-control study in Southwest China.
    Hepatology. 2017 Jun 9. doi: 10.1002/hep.29310.
    PubMed     Text format     Abstract available


  638. NG CKY, Piscuoglio S, Terracciano LM
    Molecular classification of hepatocellular carcinoma: The view from metabolic zonation.
    Hepatology. 2017 Jun 9. doi: 10.1002/hep.29311.
    PubMed     Text format    


  639. AKINROTIMI O, Riessen R, VanDuyne P, Park JE, et al
    Shp deletion prevents hepatic steatosis and when combined with Fxr loss protects against type 2 diabetes.
    Hepatology. 2017 Jun 6. doi: 10.1002/hep.29305.
    PubMed     Text format     Abstract available


  640. BAJAJ JS, Kassam Z, Fagan A, Gavis EA, et al
    Fecal Microbiota Transplant from a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial.
    Hepatology. 2017 Jun 6. doi: 10.1002/hep.29306.
    PubMed     Text format     Abstract available


  641. KWONG AJ, Goel A, Mannalithara A, Kim WR, et al
    Improved Post-Transplant Mortality After Share 35 for Liver Transplantation.
    Hepatology. 2017 Jun 6. doi: 10.1002/hep.29301.
    PubMed     Text format     Abstract available


  642. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2017;65:1783-1784.
    PubMed     Text format    


  643. DOYCHEVA I, Watt KD, Alkhouri N
    Nonalcoholic fatty liver disease in adolescents and young adults: The next frontier in the epidemic.
    Hepatology. 2017;65:2100-2109.
    PubMed     Text format     Abstract available


  644. AJMERA VH, Terrault NA, Harrison SA
    Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review.
    Hepatology. 2017;65:2090-2099.
    PubMed     Text format     Abstract available


  645. GIANNINI EG, Savarino V
    Noninvasive assessment of varices needing treatment in patients with advanced chronic liver disease: No one should be left behind.
    Hepatology. 2017;65:2131.
    PubMed     Text format    


  646. KARLAS T, Beer S, Babel J, Busse H, et al
    Do we need controlled attenuation parameter adjustment for fibrosis estimation in nonalcoholic fatty liver disease patients?
    Hepatology. 2017;65:2126-2128.
    PubMed     Text format    


  647. GUNDLING F, Tiller M, Schepp W
    Comment on "esophageal balloon tamponade vs. esophageal stent in controlling acute refractory variceal bleeding: A multicenter RCT".
    Hepatology. 2017;65:2120-2121.
    PubMed     Text format    


  648. ARIAS IM
    Coming of age and building of bridges ... reflections on the past, present, and, hesitatingly, future.
    Hepatology. 2017;65:1785-1788.
    PubMed     Text format    


    May 2017
  649. MARKWARDT D, Holdt L, Steib C, Benesic A, et al
    Plasma Cystatin C is a predictor of renal dysfunction, ACLF and mortality in patients with acutely decompensated liver cirrhosis.
    Hepatology. 2017 May 25. doi: 10.1002/hep.29290.
    PubMed     Text format     Abstract available


  650. WANG Z, Han J, Zhang H, Wu MC, et al
    Emphasis on Harms of Hepatocellular Carcinoma Surveillance: Just Pretending Innocent After Taking Advantages?
    Hepatology. 2017 May 24. doi: 10.1002/hep.29288.
    PubMed     Text format    


  651. CHIANG JYL
    Linking long non-coding RNA to control bile acid signaling and cholestatic liver fibrosis.
    Hepatology. 2017 May 24. doi: 10.1002/hep.29289.
    PubMed     Text format    


  652. MASYUK TV, Masyuk AI, Lorenzo Pisarello M, Howard BN, et al
    TGR5 contributes to hepatic cystogenesis in rodents with polycystic liver diseases via cAMP/Galphas signaling.
    Hepatology. 2017 May 23. doi: 10.1002/hep.29284.
    PubMed     Text format     Abstract available


  653. HAYASHI PH, Rockey D, Fontana RJ, Tillmann HL, et al
    Death and Liver Transplantation within Two Years of Onset of Drug-Induced Liver Injury.
    Hepatology. 2017 May 23. doi: 10.1002/hep.29283.
    PubMed     Text format     Abstract available


  654. TSOCHATZIS EA, Bosch J
    Statins in cirrhosis - ready for prime time.
    Hepatology. 2017 May 22. doi: 10.1002/hep.29277.
    PubMed     Text format    


  655. POSSO-OSORIO I, Mendez-Rayo T, Andres Jimenez C, Escobar D, et al
    Hepatic infiltration by silicone in a patient with asia syndrome.
    Hepatology. 2017 May 18. doi: 10.1002/hep.29274.
    PubMed     Text format    


  656. CHO CS, Lombard DB, Lee JH
    SIRT3 as a Regulator of Hepatic Autophagy.
    Hepatology. 2017 May 18. doi: 10.1002/hep.29271.
    PubMed     Text format    


  657. HAN D, Li J, Wang H, Su X, et al
    Circular RNA MTO1 acts as the sponge of miR-9 to suppress hepatocellular carcinoma progression.
    Hepatology. 2017 May 18. doi: 10.1002/hep.29270.
    PubMed     Text format     Abstract available


  658. SAMOYLOVA ML, Nigrini MJ, Dodge JL, Roberts JP, et al
    Biases in the reporting of hcc tumor sizes on the liver transplant waiting list.
    Hepatology. 2017 May 18. doi: 10.1002/hep.29269.
    PubMed     Text format     Abstract available


  659. BUENDIA MA, Armengol C, Cairo S
    Molecular classification of hepatoblastoma and prognostic value of the HB 16-gene signature.
    Hepatology. 2017 May 16. doi: 10.1002/hep.29262.
    PubMed     Text format    


  660. SAFIRI S, Ayubi E
    Dual photon microscopy based quantitation of fibrosis-related parameters (q-FP) to model disease progression in steatohepatitis: Methodological issues.
    Hepatology. 2017 May 16. doi: 10.1002/hep.29261.
    PubMed     Text format    


  661. ZHANG QY, Zhao LP, Tian XX, Yan CH, et al
    The novel intracellular protein CREG inhibits hepatic steatosis, obesity and insulin resistance.
    Hepatology. 2017 May 15. doi: 10.1002/hep.29257.
    PubMed     Text format     Abstract available


  662. SLIJEPCEVIC D, Roscam Abbing RLP, Katafuchi T, Blank A, et al
    Hepatic uptake of conjugated bile acids is mediated by both NTCP and OATPs and modulated by intestinal sensing of plasma bile acid levels in mice.
    Hepatology. 2017 May 12. doi: 10.1002/hep.29251.
    PubMed     Text format     Abstract available


  663. DESERT R, Rohart F, Canal F, Sicard M, et al
    Human Hepatocellular Carcinomas with a Periportal Phenotype Have the Lowest Potential for Early Recurrence after Curative Resection.
    Hepatology. 2017 May 12. doi: 10.1002/hep.29254.
    PubMed     Text format     Abstract available


  664. ZHAO E, Ilyas G, Cingolani F, Choi JH, et al
    Pentamidine Blocks Hepatotoxic Injury in Mice.
    Hepatology. 2017 May 3. doi: 10.1002/hep.29244.
    PubMed     Text format     Abstract available


  665. O'HARA SP, LaRusso NF
    Cellular Senescence, Neuropeptides and Hepatic Fibrosis: Additional Insights into Increasing Complexity.
    Hepatology. 2017 May 2. doi: 10.1002/hep.29243.
    PubMed     Text format    


  666. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2017;65:1429-1431.
    PubMed     Text format    


  667. DULAI PS, Singh S, Patel J, Soni M, et al
    Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.
    Hepatology. 2017;65:1557-1565.
    PubMed     Text format     Abstract available


  668. PARK JK, Shao M, Kim MY, Baik SK, et al
    An endoplasmic reticulum protein, Nogo-B, facilitates alcoholic liver disease through regulation of kupffer cell polarization.
    Hepatology. 2017;65:1720-1734.
    PubMed     Text format     Abstract available


  669. XIANG D, Cheng Z, Liu H, Wang X, et al
    Shp2 promotes liver cancer stem cell expansion by augmenting beta-catenin signaling and predicts chemotherapeutic response of patients.
    Hepatology. 2017;65:1566-1580.
    PubMed     Text format     Abstract available


  670. O'HARE EA, Yang R, Yerges-Armstrong LM, Sreenivasan U, et al
    TM6SF2 rs58542926 impacts lipid processing in liver and small intestine.
    Hepatology. 2017;65:1526-1542.
    PubMed     Text format     Abstract available


  671. HOU G, Chen L, Liu G, Li L, et al
    Aldehyde dehydrogenase-2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP-activated protein kinase signaling in mice.
    Hepatology. 2017;65:1628-1644.
    PubMed     Text format     Abstract available


  672. RAVA M, D'Andrea A, Doni M, Kress TR, et al
    Mutual epithelium-macrophage dependency in liver carcinogenesis mediated by ST18.
    Hepatology. 2017;65:1708-1719.
    PubMed     Text format     Abstract available


  673. WALESKY C, Goessling W
    WNTing no RASt for hepatocellular carcinoma.
    Hepatology. 2017;65:1435-1437.
    PubMed     Text format    


  674. LACKNER C, Bataller R, Burt A, Miquel R, et al
    Fibrosis evaluation by transient elastography in alcoholic liver disease: Is the histological scoring system impacting cutoff values?
    Hepatology. 2017;65:1758-1761.
    PubMed     Text format    


  675. LING Z, Liu X, Cheng Y, Shao L, et al
    Blood microbiota as a potential noninvasive diagnostic biomarker for liver fibrosis in severely obese patients: Choose carefully.
    Hepatology. 2017;65:1775-1776.
    PubMed     Text format    


  676. MARTINEZ J, Tellez L, Albillos A
    Acute variceal bleeding in patients on primary prophylaxis with nonselective beta-blockers: A poor prognosis factor?
    Hepatology. 2017;65:1774.
    PubMed     Text format    


  677. VUPPALANCHI R, Saxena R, Storniolo AMV, Chalasani N, et al
    Pseudocirrhosis and liver failure in patients with metastatic breast cancer after treatment with palbociclib.
    Hepatology. 2017;65:1762-1764.
    PubMed     Text format    


    April 2017
  678. WON JK, Yu SJ, Hwang CY, Cho SH, et al
    Protein disulfide isomerase inhibition synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma.
    Hepatology. 2017 Apr 25. doi: 10.1002/hep.29237.
    PubMed     Text format     Abstract available


  679. ZHENG X, Xu F, Liang H, Cao H, et al
    SIRT1/HSF1/HSPs Pathway is Essential for Exenatide-alleviated Lipid-induced Hepatic Endoplasmic Reticulum Stress.
    Hepatology. 2017 Apr 25. doi: 10.1002/hep.29238.
    PubMed     Text format     Abstract available


  680. SRIVASTAVA J, Robertson CL, Ebeid K, Dozmorov M, et al
    A Novel Role of Astrocyte Elevated Gene-1 (AEG-1) in Regulating Non-alcoholic Steatohepatitis (NASH).
    Hepatology. 2017 Apr 24. doi: 10.1002/hep.29230.
    PubMed     Text format     Abstract available


  681. LI S, Dou X, Ning H, Song Q, et al
    SIRT3 Acts As a Negative Regulator of Autophagy Dictating Hepatocyte Susceptibility to Lipotoxicity.
    Hepatology. 2017 Apr 24. doi: 10.1002/hep.29229.
    PubMed     Text format     Abstract available


  682. KOKUDO T, Hasegawa K, Matsuyama Y, Takayama T, et al
    Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: a Japanese nationwide survey.
    Hepatology. 2017 Apr 24. doi: 10.1002/hep.29225.
    PubMed     Text format     Abstract available


  683. BARGE S, Ziol M, Nault JC
    Autoimmune-like chronic hepatitis induced by olmesartan.
    Hepatology. 2017 Apr 24. doi: 10.1002/hep.29228.
    PubMed     Text format     Abstract available


  684. PEMBROKE T, Sebastiani G
    Hepatic steatosis, hepatitis C and human immunodeficiency viruses: A complex interplay.
    Hepatology. 2017 Apr 19. doi: 10.1002/hep.29218.
    PubMed     Text format    


  685. KUO F, Park J, Chen A
    Coil Assisted Retrograde Transvenous Obliteration and Partial Splenic Artery Embolization for Hepatic Encephalopathy.
    Hepatology. 2017 Apr 13. doi: 10.1002/hep.29212.
    PubMed     Text format    


  686. SONG Y, Liu C, Liu X, Trottier J, et al
    H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of EpCAM.
    Hepatology. 2017 Apr 13. doi: 10.1002/hep.29209.
    PubMed     Text format     Abstract available


  687. LI Y, Song Y, Zhao M, Guo Y, et al
    A Novel Role for CRTC2 in Hepatic Cholesterol Synthesis via SREBP-2.
    Hepatology. 2017 Apr 10. doi: 10.1002/hep.29206.
    PubMed     Text format     Abstract available


  688. ONO A, Goossens N, Finn RS, Schmidt WN, et al
    Persisting risk of hepatocellular carcinoma after HCV cure monitored by a liver transcriptome signature.
    Hepatology. 2017 Apr 8. doi: 10.1002/hep.29203.
    PubMed     Text format    


  689. ZHANG H, Li ZL, Xing H, Wu MC, et al
    Hepatocellular Carcinoma Surveillance: Sometimes Just Specialists' Incidental Behavior?
    Hepatology. 2017 Apr 7. doi: 10.1002/hep.29200.
    PubMed     Text format    


  690. KIM KH, Choi S, Zhou Y, Kim EY, et al
    Hepatic FXR/SHP Axis Modulates Systemic Glucose and Fatty Acid Homeostasis in Aged Mice.
    Hepatology. 2017 Apr 5. doi: 10.1002/hep.29199.
    PubMed     Text format     Abstract available


  691. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2017;65:1081-1083.
    PubMed     Text format    


  692. HADJIHAMBI A, De Chiara F, Hosford PS, Habtetion A, et al
    Ammonia mediates cortical hemichannel dysfunction in rodent models of chronic liver disease.
    Hepatology. 2017;65:1306-1318.
    PubMed     Text format     Abstract available


  693. BALIGAR P, Kochat V, Arindkar SK, Equbal Z, et al
    Bone marrow stem cell therapy partially ameliorates pathological consequences in livers of mice expressing mutant human alpha1-antitrypsin.
    Hepatology. 2017;65:1319-1335.
    PubMed     Text format     Abstract available


  694. SEBODE M, Weidemann S, Wehmeyer M, Lohse AW, et al
    Anti-TNF-alpha for necrotizing sarcoid granulomatosis of the liver.
    Hepatology. 2017;65:1410-1412.
    PubMed     Text format     Abstract available


  695. MITRA A, Yan J, Xia X, Zhou S, et al
    IL6-mediated inflammatory loop reprograms normal to epithelial-mesenchymal transition+ metastatic cancer stem cells in preneoplastic liver of transforming growth factor beta-deficient beta2-spectrin+/- mice.
    Hepatology. 2017;65:1222-1236.
    PubMed     Text format     Abstract available


  696. HALL Z, Bond NJ, Ashmore T, Sanders F, et al
    Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease.
    Hepatology. 2017;65:1165-1180.
    PubMed     Text format     Abstract available


  697. PETTA S, Wong VW, Camma C, Hiriart JB, et al
    Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values.
    Hepatology. 2017;65:1145-1155.
    PubMed     Text format     Abstract available


  698. LO GH
    The interval of endoscopic variceal ligation: The shorter the better?
    Hepatology. 2017;65:1414-1415.
    PubMed     Text format    


  699. SARITAS U, Ustundag Y
    One- or two-week interval for variceal banding after bleeding: Which one to choose?
    Hepatology. 2017;65:1415-1416.
    PubMed     Text format    


  700. SOOKOIAN S, Pirola CJ
    Nonalcoholic fatty liver disease: Biomarkers support decisions around pharmacological intervention.
    Hepatology. 2017;65:1417-1419.
    PubMed     Text format    


    March 2017
  701. TOHME S, Yazdani HO, Liu Y, Loughran P, et al
    Hypoxia mediates mitochondrial biogenesis in hepatocellular carcinoma to promote tumor growth via HMGB1 and TLR9 interaction.
    Hepatology. 2017 Mar 30. doi: 10.1002/hep.29184.
    PubMed     Text format     Abstract available


  702. LIU P, Ge M, Hu J, Li X, et al
    A functional mTORC1 signaling is indispensable for c-Myc driven hepatocarcinogenesis.
    Hepatology. 2017 Mar 30. doi: 10.1002/hep.29183.
    PubMed     Text format     Abstract available


  703. SORIA A, Fabbiani M, Lapadula G, Gori A, et al
    Unexpected viral relapses in HCV-infected patients diagnosed with hepatocellular carcinoma during treatment with DAAs.
    Hepatology. 2017 Mar 30. doi: 10.1002/hep.29181.
    PubMed     Text format    


  704. SORIANO G, Bajaj JS
    Grading the range of hepatic encephalopathy from overt to covert: Animals to the Rescue!
    Hepatology. 2017 Mar 30. doi: 10.1002/hep.29186.
    PubMed     Text format    


  705. CHANG FM, Wang YP, Lang HC, Tsai CF, et al
    Statins decrease the risk of decompensation in HBV- and HCV-related cirrhosis: A population-based study.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29172.
    PubMed     Text format     Abstract available


  706. SASAKI R, Devhare PB, Steele R, Ray R, et al
    Hepatitis C virus induced CCL5 secretion from macrophages activates hepatic stellate cells.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29170.
    PubMed     Text format     Abstract available


  707. NAHON P, Seror O, Durand-Zaleski I
    Reply to: <<Screening for Hepatocellular carcinoma: A drug safety issue>>.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29174.
    PubMed     Text format    


  708. BRAILLON A
    Screening for hepatocellular carcinoma: A drug safety issue.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29173.
    PubMed     Text format    


  709. DE MATTOS AZ, Miozzo SA, Tovo CV, de Mattos AA, et al
    Risks of proton pump inhibitors for cirrhotic patients - the controversy remains.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29132.
    PubMed     Text format    


  710. MOLLER S, Hove JD
    Assessment of systolic function in the evaluation of patients with cirrhosis.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29163.
    PubMed     Text format    


  711. LI X, Liu R, Yang J, Sun L, et al
    The role of LncRNA H19 in gender disparity of cholestatic liver injury in Mdr2-/- mice.
    Hepatology. 2017 Mar 8. doi: 10.1002/hep.29145.
    PubMed     Text format     Abstract available


  712. MAIERS JL, Kostallari E, Mushref M, deAssuncao TM, et al
    The unfolded protein response mediates fibrogenesis and collagen I secretion through regulating TANGO1 in mice.
    Hepatology. 2017;65:983-998.
    PubMed     Text format     Abstract available


  713. ZHU B, Wei L, Rotile N, Day H, et al
    Combined magnetic resonance elastography and collagen molecular magnetic resonance imaging accurately stage liver fibrosis in a rat model.
    Hepatology. 2017;65:1015-1025.
    PubMed     Text format     Abstract available


  714. ALONSO EM, Horslen SP, Behrens EM, Doo E, et al
    Pediatric acute liver failure of undetermined cause: A research workshop.
    Hepatology. 2017;65:1026-1037.
    PubMed     Text format     Abstract available


  715. KISSELEVA T
    The origin of fibrogenic myofibroblasts in fibrotic liver.
    Hepatology. 2017;65:1039-1043.
    PubMed     Text format     Abstract available


  716. KARVELLAS CJ, Speiser JL, Tremblay M, Lee WM, et al
    Elevated FABP1 serum levels are associated with poorer survival in acetaminophen-induced acute liver failure.
    Hepatology. 2017;65:938-949.
    PubMed     Text format     Abstract available


  717. MUSSO G, Cassader M, Paschetta E, Gambino R, et al
    Pioglitazone for advanced fibrosis in nonalcoholic steatohepatitis: New evidence, new challenges.
    Hepatology. 2017;65:1058-1061.
    PubMed     Text format    


  718. ESHRAGHIAN A
    High prevalence of nonalcoholic fatty liver disease in the middle east: Lifestyle and dietary habits.
    Hepatology. 2017;65:1077.
    PubMed     Text format    


    February 2017
  719. ZUBIETE-FRANCO I, Fernandez-Tussy P, Barbier-Torres L, Simon J, et al
    Deregulated neddylation in liver fibrosis.
    Hepatology. 2017;65:694-709.
    PubMed     Text format     Abstract available


  720. KAIKKONEN JE, Wurtz P, Suomela E, Lehtovirta M, et al
    Metabolic profiling of fatty liver in young and middle-aged adults: Cross-sectional and prospective analyses of the Young Finns Study.
    Hepatology. 2017;65:491-500.
    PubMed     Text format     Abstract available


  721. GOLDRING C, Antoine DJ, Bonner F, Crozier J, et al
    Stem cell-derived models to improve mechanistic understanding and prediction of human drug-induced liver injury.
    Hepatology. 2017;65:710-721.
    PubMed     Text format     Abstract available


  722. HU H, Zhu W, Qin J, Chen M, et al
    Acetylation of PGK1 promotes liver cancer cell proliferation and tumorigenesis.
    Hepatology. 2017;65:515-528.
    PubMed     Text format     Abstract available


  723. MA JZ, Yang F, Zhou CC, Liu F, et al
    METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N6 -methyladenosine-dependent primary MicroRNA processing.
    Hepatology. 2017;65:529-543.
    PubMed     Text format     Abstract available


  724. DEL CHIERICO F, Nobili V, Vernocchi P, Russo A, et al
    Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach.
    Hepatology. 2017;65:451-464.
    PubMed     Text format     Abstract available


  725. HATTING M, Tacke F
    From NAFLD to HCC: Is IL-17 the crucial link?
    Hepatology. 2017;65:739-741.
    PubMed     Text format    


  726. SINTUSEK P, Dhawan A
    Lipid and copper metabolism in humans with wilson disease: Enigmatic relationship.
    Hepatology. 2017;65:753-755.
    PubMed     Text format    


  727. THIELE M, Madsen BS, Krag A
    Is liver stiffness equal to liver fibrosis?
    Hepatology. 2017;65:749.
    PubMed     Text format    


    January 2017
  728. WANG Y, Aoki H, Yang J, Peng K, et al
    The role of S1PR2 in bile acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice.
    Hepatology. 2017 Jan 24. doi: 10.1002/hep.29076.
    PubMed     Text format     Abstract available


  729. ARORA P, Basu A, Schmidt ML, Clark GJ, et al
    NS5B Promotes Degradation of the NORE1A Tumor Suppressor to Facilitate Hepatitis C Virus Replication.
    Hepatology. 2017 Jan 16. doi: 10.1002/hep.29049.
    PubMed     Text format     Abstract available


  730. BJORNSSON ES, Jonasson JG
    Idiosyncratic drug-induced liver injury associated with bile duct loss and vanishing bile duct syndrome: Rare but has severe consequences.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29040.
    PubMed     Text format    


  731. MARONI L, Hohenester SD, van de Graaf SF, Tolenaars D, et al
    Knockout of the Primary Sclerosing Cholangitis-Risk Gene Fut2 Causes Liver Disease in Mice.
    Hepatology. 2017 Jan 5. doi: 10.1002/hep.29029.
    PubMed     Text format     Abstract available


  732. ALCARAZ-QUILES J, Titos E, Casulleras M, Pavesi M, et al
    Polymorphisms in the IL-1 gene cluster influence systemic inflammation in patients at risk for acute-on-chronic liver failure.
    Hepatology. 2017;65:202-216.
    PubMed     Text format     Abstract available


  733. DECARIS ML, Li KW, Emson CL, Gatmaitan M, et al
    Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood.
    Hepatology. 2017;65:78-88.
    PubMed     Text format     Abstract available


  734. NAVARRO VJ, Khan I, Bjornsson E, Seeff LB, et al
    Liver injury from herbal and dietary supplements.
    Hepatology. 2017;65:363-373.
    PubMed     Text format     Abstract available


  735. WANG J, Koh HW, Zhou L, Bae UJ, et al
    Sirtuin 2 aggravates postischemic liver injury by deacetylating mitogen-activated protein kinase phosphatase-1.
    Hepatology. 2017;65:225-236.
    PubMed     Text format     Abstract available


  736. AJMERA V, Perito ER, Bass NM, Terrault NA, et al
    Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease.
    Hepatology. 2017;65:65-77.
    PubMed     Text format     Abstract available


  737. LEUNG JC, Loong TC, Wei JL, Wong GL, et al
    Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients.
    Hepatology. 2017;65:54-64.
    PubMed     Text format     Abstract available


  738. MEDINA-CALIZ I, Robles-Diaz M, Lucena MI, Andrade RJ, et al
    Drug-induced liver and skin reactions: In need of a consensus definition.
    Hepatology. 2017;65:391.
    PubMed     Text format    


  739. LIU K, Xu W, Wong VW
    Serum biomarkers for nonalcoholic fatty liver disease: Are we there yet?
    Hepatology. 2017;65:8-11.
    PubMed     Text format    


  740. LO GH
    The use of esophageal stent in controlling acute refractory variceal bleeding.
    Hepatology. 2017;65:385-386.
    PubMed     Text format    


    December 2016
  741. WANG KS, Tiao G, Bass LM, Hertel PM, et al
    Analysis of surgical interruption of the enterohepatic circulation as a treatment for pediatric cholestasis.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29019.
    PubMed     Text format     Abstract available


  742. QIU YL, Gong JY, Feng JY, Wang RX, et al
    Defects in MYO5B are associated with a spectrum of previously undiagnosed low gamma-glutamyltransferase cholestasis.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29020.
    PubMed     Text format     Abstract available


  743. SAVALE L, Sattler C, Coilly A, Conti F, et al
    Long-term outcome in liver transplantation candidates with portopulmonary hypertension.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28990.
    PubMed     Text format     Abstract available


  744. BONKOVSKY HL, Kleiner DE, Gu J, Odin JA, et al
    Clinical Presentations and Outcomes of Bile Duct Loss caused by Drugs and Herbal and Dietary Supplements.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28967.
    PubMed     Text format     Abstract available


  745. JANSEN PL, Ghallab A, Vartak N, Reif R, et al
    The ascending pathophysiology of cholestatic liver disease.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28965.
    PubMed     Text format     Abstract available


    September 2016
  746. KULKARNI SR, Soroka CJ, Hagey LR, Boyer JL, et al
    Sirtuin 1 activation alleviates cholestatic liver injury in a cholic acid fed mouse model of cholestasis.
    Hepatology. 2016 Sep 17. doi: 10.1002/hep.28826.
    PubMed     Text format     Abstract available


    August 2016
  747. GONZALES E, Taylor SA, Davit-Spraul A, Thebaut A, et al
    MYO5B mutations cause cholestasis with normal serum gamma-glutamyl transferase activity in children without microvillous inclusion disease.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28779.
    PubMed     Text format     Abstract available


    July 2016
  748. VERGANI D, Mieli-Vergani G
    Mouse model of primary biliary cholangitis with a striking female predominance: A new powerful research tool.
    Hepatology. 2016 Jul 7. doi: 10.1002/hep.28718.
    PubMed     Text format    


    June 2016
  749. ARAB JP, Karpen SJ, Dawson PA, Arrese M, et al
    Bile acids & nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives.
    Hepatology. 2016 Jun 30. doi: 10.1002/hep.28709.
    PubMed     Text format     Abstract available


  750. SPENGLER EK, Kleiner DE, Fontana RJ
    Vemurafenib-induced Granulomatous hepatitis.
    Hepatology. 2016 Jun 23. doi: 10.1002/hep.28692.
    PubMed     Text format    


  751. FENG S, Demetris AJ, Spain KM, Kanaparthi S, et al
    Five year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R.
    Hepatology. 2016 Jun 15. doi: 10.1002/hep.28681.
    PubMed     Text format     Abstract available


    April 2016
  752. WU N, Meng F, Invernizzi P, Bernuzzi F, et al
    The secretin/secretin receptor axis modulates liver fibrosis through changes in TGF-beta1 biliary secretion.
    Hepatology. 2016 Apr 26. doi: 10.1002/hep.28622.
    PubMed     Text format     Abstract available


    March 2016
  753. ALVARO D, Gaudio E
    Biliary tree stem cell subpopulations.
    Hepatology. 2016 Mar 12. doi: 10.1002/hep.28546.
    PubMed     Text format    


    February 2016
  754. WU W, Patel A, Kyostila K, Lohi H, et al
    Genome-wide Association Study in Mice Identifies Loci Affecting Liver-related Phenotypes Including Sel1l Influencing Serum Bile Acids.
    Hepatology. 2016 Feb 9. doi: 10.1002/hep.28495.
    PubMed     Text format     Abstract available


  755. OIKAWA T
    Cancer Stem Cells and Their Cellular Origins in Primary Liver and Biliary Tract Cancers.
    Hepatology. 2016 Feb 5. doi: 10.1002/hep.28485.
    PubMed     Text format     Abstract available


    November 2015
  756. FERNANDEZ J, Tandon P, Mensa J, Garcia-Tsao G, et al
    Antibiotic prophylaxis in cirrhosis: Good and bad.
    Hepatology. 2015 Nov 3. doi: 10.1002/hep.28330.
    PubMed     Text format     Abstract available


    July 2015
  757. HENRY ZH, Northup PG
    Baclofen for the treatment of muscle cramps in patients with cirrhosis: A new alternative.
    Hepatology. 2015 Jul 14. doi: 10.1002/hep.27988.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: